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Abstract
The proximate causes of ageing and the biological processes that determine
lifespan are still unclear. However, many studies using model organisms
have led to the identification of genes associated with longevity. While there
is a clear link between changes in metabolism and changes in longevity,
there has been relatively little ageing–related research that has measured
metabolites directly. Metabolic profiling of low molecular weight metabolites
(metabolomics) has an advantage over other ‘omics’ techniques, in that
it directly samples the metabolic changes in an organism, and integrates
information from changes at the gene, transcript and protein levels, as well
as post–translational modification.
This thesis demonstrates that metabolic profiling provides a new and
useful phenotyping tool for studying ageing in the nematode Caenorhabditis
elegans. Using both nuclear magnetic resonance (NMR) spectroscopy and gas
chromatography–mass spectrometry (GC–MS), I have identified metabolites
that are linked with long life. I have carried out the first characterisation
of the C. elegans metabolome throughout both development and ageing.
Comparing these metabolic changes in wild type worms with those seen in a
long–lived mutant aid the understanding of when and how mutant worms
acquire their long–lived phenotype. In addition to this, I have examined the
effects on metabolism of a commonly used technique in C. elegans ageing
research: the inhibition of DNA synthesis to maintain synchronous ageing
populations. This provided a way to control for the effects of this technique
when used in my work, but also demonstrated that its use may result in
artefacts in data. I have also investigated the effect of mutation accumulation
on the C. elegans metabolic profile. I have shown that metabolomics provides
a way to obtain new phenotypes in this type of study, and novel information
about the variation that occurs as a result of spontaneous mutation.
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1 Introduction
1.1 Aims and objectives
The proximate causes of ageing, and the biological processes that determine
lifespan are still unclear. However, many studies using model organisms
have led to the identification of genes that can be associated with longevity.
Metabolomics, or metabolic profiling of low molecular weight metabolites
(Fiehn, 2002), is an effective way to break down the complex longevity
phenotype into smaller elements to provide intermediate phenotypes of
ageing. This work will examine the changes in metabolism that occur with
the ageing process in the nematode Caenorhabditis elegans. It will investigate
the metabolic features that are associated with long–lived animals, during
both development and the ageing process, and the features associated with
with altered fecundity, a trait often associated with ageing. It will also
consider the effect of the accumulation of mutations on the C. elegans
metabolic profile.
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1.2 Caenorhabditis elegans
Caenorhabditis elegans is a free–living, soil dwelling nematode, around 1 mM
in length at adulthood, and comprising only 959 cells. Fed on bacteria,
worms can be easily and cheaply cultured in large numbers under laboratory
conditions, and frozen for long–term storage. As a multicellular eukaryote
with a short generation time, C. elegans has been used as a model organism
since 1974 (Brenner, 1974). The lineage of all 959 cells of a hermaphrodite
is known and therefore C. elegans is a common choice for the study of
development. The C. elegans genome has been fully sequenced (C. elegans
Sequencing Consortium, 1998) – the first multicellular organism genome
sequenced – and it is relatively easy to disrupt specific gene function with
RNA interference (RNAi), by injection, soaking or by culturing worms
on genetically transformed E. coli (Murphy et al., 2003). The C. elegans
genome is freely available via www.wormbase.org (Harris, 2004), a central
data repository for information on C. elegans as well as other nematodes.
This makes C. elegans ideal for use in genomic studies, as well as for use in
proteomics, transcriptomics and metabolomics.
Most C. elegans individuals are hermaphrodites (around 99.5% of the
population on average), with only a small number of males, which are a
result of chromosome non–disjunction (Kadandale & Singson, 2004). Males
contain exactly 72 cells more than hermaphrodite worms, and these form the
male reproductive organs. Hermaphrodites are able to self–fertilise, however
if mated with a male, eggs are preferentially fertilised by sperm from the
male rather than sperm from the hermaphrodite, and this greatly increases
the number of progeny produced (Wood, 1988).
20
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Egg
L1
L3
L4
Adult
L2
Dauer
Figure 1.1: The life cycle of wild type C. elegans consists of an embryonic stage, four
larval stages (L1–L4) and an adult stage. Each stage ends with a cuticle molt followed
by the formation of a new cuticle. Depending on culture temperature, the development
of C. elegans from egg to adult takes 3–5 days. Under unfavourable conditions, worms
enter an alternate L3 stage, the dauer larva. (Diagram adapted from Epstein & Shakes
(1995), photographs adapted from Fielenbach & Antebi (2008)).
The C. elegans life cycle is shown in Figure 1.1, and consists of embryoge-
nesis and four larval stages (L1–L4) before adulthood. At 20℃, gastrulation
takes place over approximately three hours before the egg is laid via the
vulva (Wood, 1988). After 7–9 hours, the L1 worm emerges from the egg and
then continues through four molts, which occur at the transition from L1 to
L2, from L2 to L3, from L3 to L4 and finally from L4 to adult. Worms have
a flexible exoskeleton, the cuticle, consisting mainly of cross–linked collagens
forming an extracellular matrix. Molting involves the shedding of old cuticle,
with a new cuticle generated at each larval stage, allowing for growth of the
worm. The cuticle changes in composition and relative thickness at each
stage, along with the expression of surface proteins (Cox et al., 1981a,b). At
20℃, the four molts take place over the course of around forty hours. At
the final molt, both gonadogenesis and spermatogenesis are complete and
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oogenesis begins (Wood, 1988). The progression from embryo to adult takes
around three days in total and egg production begins at around 65 hours
after worms have hatched (Byerly et al., 1976). Between 200 and 300 viable
eggs are produced by self fertilisation.
In unfavourable conditions, such as overcrowding, low food availability
and high temperatures, C. elegans, at the L2 stage, is able to enter into
facultative diapause and develop into an alternative, specialised, third larval
stage called the dauer larva. Dauer larvae are non–feeding, have arrested
development, and are able to survive for several months, with development
continuing as normal when worms are returned to favourable conditions
(Wood, 1988). Adult worms that have undergone this dauer diapause have
the same fecundity and lifespan as worms that have progressed from embryo
to adult without this stage (Wood, 1988).
1.3 Ageing
The genetic control of ageing
Its relatively short average lifespan of 2–3 weeks depending on temperature
and food availability (Vanfleteren & Braeckman, 1999), makes C. elegans an
ideal model organism for studying ageing. In addition to this, many single
gene mutations have been discovered to increase C. elegans lifespan. The
first was the age-1 mutation, found to increase maximum hermaphrodite
lifespan by up to 110%, depending on temperature (Friedman & Johnson,
1988). Age-1 encodes the homolog of mammalian phopshoinositide-3-OH
kinase (PI3K). The next longevity–associated gene to be discovered was
daf-2 (Kenyon et al., 1993), which more than doubled wild type lifespan.
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This increase in longevity was found to depend on another gene, daf-16.
Both daf-2 and daf-16 also regulate the formation of long–lived dauer larvae.
These three genes are all components of the insulin/IGF-1 signalling (IIS)
pathway (Morris et al., 1996; Ogg et al., 1997; Lin, 1997; Kimura, 1997). A
simplified version of this pathway is shown in Figure 1.2.
DAF-16
DAF-16
Akt/PKB
AGE-1/
 PI3K
Nucleus
Transcription
Inactive
Insulin-like 
  ligands      DAF-2 
(Insulin / IGF-1 
    receptor)
    FOXO-family
    transcription 
         factor
 Numerous 
downstream 
   factors
Longevity
Figure 1.2: Daf-2 encodes a receptor tyrosine kinase, which binds an insulin–like
substrate. This initiates a cascade that involves the activation of the age-1 encoded
kinase, which then activates protein kinase B (PKB), a serine–threonine kinase, encoded
by Akt as well as serum– and glucocorticoid–inducible kinase (SGK, not shown). PKB
and SGK then phosphorylate the FOXO–related forkhead transcription factor DAF-16
and as a result of this phosphorylation, DAF-16 is retained in the cytoplasm and so is not
transcriptionally active. Reduced insulin / IGF-2 signalling results in unphosphorylated
DAF-16 entering the nucleus, resulting in the activation of many genes and an increase
in longevity.
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The daf-2 gene encodes a receptor tyrosine kinase, which binds an insulin–
like substrate. This initiates a cascade that involves the activation of the
age-1 encoded kinase, which then activates protein kinase B (PKB), a serine–
threonine kinase, encoded by Akt, as well as serum– and glucocorticoid–
inducible kinase (SGK). PKB and SGK then phosphorylate the FOXO–
related forkhead transcription factor DAF-16 and as a result of this phospho-
rylation, DAF-16 is retained in the cytoplasm and so is not transcriptionally
active (Paradis & Ruvkun, 1998; Paradis et al., 1999; Hertweck et al., 2004).
However, when insulin/IGF-1 signalling is reduced, for example, by mutation
of daf-2 or age-1, unphosphorylated DAF-16 is able to enter the nucleus,
resulting in the activation of many genes, including those associated with
protection against oxidative stress and heat shock, those linked with au-
tophagy and innate immunity as well as other genes associated with survival
(Murphy et al., 2003; Lee et al., 2003b; McElwee, 2004; Honda & Honda,
1999; Melendez, 2003). Null daf-16 (daf-16(0)) mutations fully repress the
longevity effects of IIS mutations (Kenyon, 2005). Downregulation of IIS has
also been found to promote longevity and stress resistance in both Drosophila
(Clancy, 2001; Tatar, 2001) and in mice (Blu¨her et al., 2003; Holzenberger
et al., 2003).
Much of the work contained within this thesis focusses on mutations in
daf-2, however there is considerable variation in the phenotype resulting from
daf-2 mutation, depending on the allele studied. The daf-2 alleles studied
here – daf-2(m41) and daf-2(e1370) – represent hypomorphic mutations
(Gems et al., 1998), i.e., mutations that cause a partial loss of gene function,
reducing expression without the complete loss of function observed as a result
of a null mutation. These alleles are known to show differences in longevity,
fecundity, and thermotolerance, with daf-2(e1370) generally longer–lived,
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less fecund, and with increased intrinsic thermotolerance compared with
daf-2(m41) (Larsen et al., 1995; Gems et al., 1998).
Reactive oxygen species
The ‘rate–of–living’ hypothesis states that lifespan is linked with the metabolic
rate of an organism. This hypothesis was generated based on the observation
that species with high metabolic rates generally have shorter lifespans than
those with lower metabolic rates. A mechanism to support this idea was
put forward by Harman (1956), who suggested that reactive oxygen species
(ROS), created within cells as part of normal metabolism, resulted in the ac-
cumulation of cellular damage. The term ROS can be used to describe many
different molecules and free radicals (chemical species with one unpaired
electron and therefore powerful oxidising agents). These species include
superoxide anions, hydrogen peroxide and hydroxide radicals, and may cause
oxidation and damage of cell components. This idea of free radicals pro-
vided evidence to support the rate–of–living theory; a higher metabolic rate
produces a greater number of ROS in a given period of time, leading to
increased cellular damage and therefore a shorter lifespan. Conversely, a
slower metabolic rate results in relatively fewer ROS per unit time, less
cellular damage and increased longevity. However, this free–radical theory of
ageing appears to be more accurate than the closely–related rate–of–living
hypothesis. Some species, for example, birds, have relatively high metabolic
rates and relatively long lifespans and it has been found that this is due
to decreased intracellular production of ROS in these species (Ku et al.,
1993).
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The ageing process leads to increased numbers of malfunctioning mitochon-
dria, decreased biogenesis of mitochondria and increased oxidative damage
(Guarente, 2008; Lo´pez-Lluch et al., 2008). Most of the ROS produced
within cells originate in mitochondria, and in particular at complexes I and
III (NADH dehydrogenase and ubiquinone-cytochrome c reductase respec-
tively) (Turrens, 1997). Both nuclear and mitochondrial DNA accumulate
damage as a result of oxidation, but mitochondrial DNA (Beckman & Ames,
1998), possibly due to the close proximity to the most important source of
ROS production, is more sensitive to oxidative damage than nuclear DNA.
Damaged mitochondrial DNA is likely to lead to impaired mitochondrial
function, and these damaged mitochondria produce more ROS, resulting
in additional DNA damage and a continuing downward spiral (Finkel &
Holbrook, 2000).
A system of antioxidants helps to reduce the net amount of ROS. This de-
fence system includes superoxide dismutase (SOD), converting superoxide to
hydrogen peroxide (McCord & Fridovich, 1969), and catalase and glutathione
peroxidase, both converting hydrogen peroxide to water. Overexpression of
catalase and SOD has long been known to increase longevity in Drosophila
(Orr & Sohal, 1994) and treatment with SOD and catalase mimetics increase
lifespan in C. elegans (Melov et al., 2000). The amount of oxidative stress a
cell experiences is a result of the balance between the production of ROS,
and the production and effectiveness of the antioxidant system (Finkel &
Holbrook, 2000). External factors such as ultraviolet radiation and hyper-
thermia may result in the production of high levels of ROS and oxidative
stress. This leads to the activation of pathways including p53 activation
and the heat shock response (reviewed by Finkel & Holbrook, 2000). Heat
shock proteins are involved in ensuring the correct folding, transport and
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degradation of other proteins within the cell and the activity of the heat
shock response has been shown to decrease with age (Finkel & Holbrook,
2000).
In addition to causing damage to cellular components directly, ROS
also result in oxidative glycation reactions between reducing sugars and
protein amino groups, giving Advanced Glycation End products (AGEs).
These end products are highly reactive, causing protein aggregation through
crosslinking, and contributing to the ageing phenotype (reviewed by Singh
et al., 2001). Additionally, AGE formation induces the production of free
radicals, and decreases the activity of SOD. Together, these processes further
increase the level of oxidative damage, and, in turn, the production of AGEs
(Singh et al., 2001).
Mitochondria and ageing
In nematodes, mutations in many nuclear genes that encode mitochondrial
proteins increase longevity, via a decrease in the rate of metabolism or a
decrease in oxidative phosphorylation rate, which leads to reduced levels
of reactive oxygen species. The first was discovered by Felkai et al. (1999),
who found that worms with mutations in the gene clk-1, which codes for a
mitochondrial hydroxylase required for the synthesis of coenzyme Q, were
long–lived. The next longevity–associated mitochondrial mutation to be
identified was that of the isp-1 gene, which encodes the Rieske iron–sulfur
subunit of complex III of the Electron Transport Chain (ETC) (Feng et al.,
2001). In addition to these genetic mutations, the reduced synthesis of many
mitochondrial components increase longevity, the genes coding for these
proteins identified by genome–wide RNAi screens (Dillin, 2002; Lee et al.,
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2003a). As well as increasing lifespan, these mutations result in lowered
fecundity, increases in developmental times and slowing of movement. The
mechanisms by which these mutations influence longevity are unclear. It may
be the case that mitochondrial mutations result in a reduced metabolic rate,
decreasing ROS production (Feng et al., 2001). Alternatively, mutations
in the ETC may lead to an increase in electron leakage, increasing the
production of ROS, and activating an adaptive hormesis response (Ventura
et al., 2006). Hormesis is the process by which low levels of stress lead to
the activation of defence mechanisms, here resulting in an increase in the
resistance to oxidative stress and therefore an increase in longevity. While
many of these mitochondrial mutations appear to show a synergistic effect
with daf-2 mutations, and extend lifespan independently of DAF-16 (Feng
et al., 2001; Wong et al., 1995; Dillin, 2002), some have been found to
require DAF-16 for lifespan extension (Lee et al., 2003a; Curran & Ruvkun,
2007).
Dietary restriction
Dietary restriction (DR) extends the life span of C. elegans as it does in many
other animals (Heilbronn & Ravussin, 2003). The Sir2 gene, shown to be
involved in lifespan extension by DR, was first identified in the budding yeast
Saccharomyces cerevisiae (Lin et al., 2000). In C. elegans, the longevity–
increasing effects of DR can be seen in worms fed a restricted diet and also
in various mutants where feeding is affected. For example, eat-2 mutants are
unable to feed properly due to a larynx defect, and show increased longevity
(Lakowski & Hekimi, 1998). Life span extension in this way is not dependent
on functional DAF-16, but instead requires Foxa transcription factor PHA-4
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(Panowski et al., 2007). PHA-4 is not required for life span extension that
occurs as a result of other regulating pathways, but is essential for all forms
of DR–induced increases in longevity – in mutants such as eat-2 and also in
worms fed bacteria at a limited concentration (Walker et al., 2005).
Dietary restriction alleviates the decrease in both mitochondrial activity
and biogenesis that occur with age. In mammals, it leads to increased
expression of PGC-1α, a master regulator of mitochondrial biogenesis and
the ROS defence system. It also increases SIRT1 expression. SIRT1 is
the closest homologue of yeast SIR2, and its expression can be linked with
an increase in mitochondrial biogenesis, decrease in ROS production and
lifespan extension (Bishop & Guarente, 2007). Increased mitochondrial
biogenesis is beneficial as it leads to more functional mitochondria and
therefore less mitochondrial ROS production (Bishop & Guarente, 2007).
Overall, these changes lead to a decrease in oxidative damage in metabolically
active tissues. This has been shown to be the case in both mice and in
humans (Civitarese et al., 2007; Nisoli et al., 2005). CR appears to affect
mitochondrial biogenesis and ROS defence genes via endothelial nitric oxide
synthase (eNOS) expression (Nisoli et al., 2004, 2005). eNOS–derived nitric
oxide directly increases mitochondrial biogenesis (Nisoli et al., 2004) and
eNOS Null mutant mice have age–related diseases, a reduced lifespan, reduced
mitochondrial biogenesis and reduced SIRT1 expression (Li et al., 2004).
The C. elegans homologue of SIRT has yet to be convincingly connected
with DR (Bishop & Guarente, 2007), but DR in C. elegans does induce
mitochondrial respiration and increases oxidative stress to extend lifespan
by hormesis (Schulz et al., 2007).
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Reproduction and Ageing
When internal resources are limited and insufficient to pay all construction
and maintenance costs for two life history traits that share a common resource
pool, the result is a trade–off. If there is no variation in resource input, then
two traits linked in such a trade–off will be negatively correlated (Zera &
Harshman, 2001). In this case, if internal reserves allocated to reproduction
in C. elegans limit resources available for somatic maintenance, the result
will be a trade–off between reproduction and longevity.
This given, it is unsurprising that the laser ablation of germ–line precursors
results in a 60% increase in life span, and germ–line mutants (which have a
phenotype much like worms with laser–ablated germ–lines) are also long–lived
(Mukhopadhyay & Tissenbaum, 2007). However, while the specific ablation of
the germ–line extends life span, ablation of reproduction altogether does not
affect longevity. Removal of the entire gonad (that is, both the somatic gonad
and the germ–line), has little or no effect on life span, despite the complete
removal of reproduction. For this reason, it has been suggested that the idea
of a trade–off between reproduction and longevity is too simplistic, and that
the germ–line sends a specific molecular signal that represses longevity and
that the somatic gonad produces a signal opposing the germ–line signal, so
controlling lifespan (Hsin & Kenyon, 1999). Germ–line stem-cells, rather
than the germ cells themselves appear to be the important factor in wild
type longevity (Gems & Riddle, 1996).
Where manipulations are made to attempt to alter the allocation of
resources in some way, the strength of a signal may inadvertently be changed,
giving the impression of a trade–off or cost of reproduction, where this may
not be the case. The fact that elimination of reproduction by removing the
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entire gonad has no (or even a detrimental) effect on life span is contrary
to the resource allocation trade–off theory. However, it is possible that life
span extension following removal of the germ–line requires a signal of some
sort from the somatic gonad. It appears that the positive effect of possessing
a somatic gonad balances the deleterious effect of possessing a germ–line, so
that eliminating the entire gonad leaves longevity unchanged (Leroi, 2001).
To properly test this, ideally the effects on lifespan of germ–line in the
absence of somatic gonad would be examined, however the presence of germ
cells relies upon the somatic gonad.
The germ–line signal, with its negative effect on survival, depends on the
presence of a functioning insulin signalling cascade (Patel et al., 2002). Life
span extension as a result of an absent germ–line (either through mutation or
laser ablation) is dependent on the presence of functional DAF-16, and DAF-
16 activity is needed specifically during adulthood for life span extension
by germ–line ablation. Daf-16 mutations suppress the longevity–enhancing
effects of germ–line ablation, and it seems that in wild type worms, daf-16
responds to a signal from germ cells much as it responds to a signal mediated
by daf-2.
Reduced fecundity is observed to varying degrees in daf-2 mutants (alleles
e1370, m596, m41, etc.) (Gems et al., 1998), but germ–line ablation in
these mutants further increases life span, indicating separate pathways and
that life span extension in daf-2 mutants is not a result of a trade–off and
the allocation of resources away from reproduction and towards somatic
maintenance. Daf-2 mutation and germ–line ablation have synergistic effects
on life span, so that when the activity of both germ–line signals and daf-
2 decreases, daf-16 activity is permitted to increase even further (Hsin
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& Kenyon, 1999). Germ–line signals and wild type DAF-2 activity act
in parallel to shorten life span by down regulating daf-16, i.e. germ–line
signalling may converge into the IIS pathway downstream of daf-2 to affect
activation of DAF-16.
Wild type DAF-2 inhibits life span extension in a similar way to the germ–
line signal, and so daf-2 mutants lacking both the germ–line and somatic
gonad still have an increased life span relative to wild type, implying that
the presence of the somatic gonad is not necessary for life span extension
(Barnes & Partridge, 2003).
Metabolism and ageing
Longevity pathways can be associated with specific enzymes involved in
metabolism, with many metabolism–linked genes activated by DAF-16 (Lee
et al., 2003b; Murphy et al., 2003; Halaschek-Wiener, 2005). In addition
to this, proteomic studies have been used to investigate the link between
metabolism and longevity in C. elegans. For example, it has been found
that wild type worms have a greater abundance of proteins involved with
lipid transport and translation elongation than daf-2 worms, while these
mutants have a comparatively high abundance of proteins involved in the
biosynthesis of amino acids and the metabolism of ROS, as well as those
involved with carbohydrate metabolism (Dong et al., 2007).
Longevity–associated pathways have also been linked with key regulators
of metabolism in C. elegans. The ratio of AMP to ATP is a measure of energy
availability, and this ratio increases with age and changes in response to
environmental stress. In worms, the AMP–activated protein kinase subunit
AAK-2 acts as a sensor, being activated by AMP. Both environmental stress
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and lowered insulin signalling have been found to increase longevity via
aak-2, which acts in parallel to daf-16 to control lifespan (Apfeld et al.,
2004). Wang et al. (2008) used laser ablation of germ line precursor cells to
investigate fat metabolism in these worms. It was found that germline stem
cells modulate lipid metabolism by inducing a specific fat lipase throughout
the worm, which in turn affects longevity. Lipid hydrolysis was found to be
activated via the daf-16 pathway.
TOR (target–of–rapamycin) protein kinases have been shown to respond to
nutrients and growth factors to control the growth of cells. They are involved
in signalling to downstream translation machinery in response to environmen-
tal nutrient availability (Kim et al., 2002; Hara et al., 2002). In C. elegans, the
TOR homologue regulates dauer diapause, altering metabolism in response
to changes in environmental nutrient abundance to cause the accumulation of
lipids. The transcription of raptor, which is encoded by daf-15 and is a regu-
latory associated protein of TOR, is regulated by DAF-16. Together, raptor
and TOR regulate metabolism and increase lifespan (Jia et al., 2004).
In addition to this, long–lived dauer larvae are known to have altered
metabolism, as reviewed by Braeckman et al. (2000), with a decreased
metabolic rate and a reliance on lipids as a primary energy reserve rather
than the combination of lipid and carbohydrate metabolism observed in non–
dauer worms. Dauers also excrete dauer inducing pheromone in response
to changes in food–availability. This pheromone consists of ascaroside
derivatives with short, fatty acid–like side chains (Butcher et al., 2009).
Changes in metabolism associated with dauer formation have been directly
measured by Fuchs et al. (2010), with some metabolites – phosphoserine
and hydroxyproline – found to be unique to the dauer stage. It is possible
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that these modified amino acids are a result of the use of the extracellular
matrix, as well as other proteins, as another energy store.
1.4 Metabolomics
Metabolomics is an untargeted approach that allows the quantification of
many metabolites – the intermediates and products of metabolism – in a
given tissue or organism, at a given time, simultaneously (Goodacre et al.,
2004). Changes in environment, disease and mutation may all cause changes
in the levels of metabolites in a system, and metabolomics allows an insight
into these responses (Nicholson et al., 1999; Fiehn, 2002; Want et al., 2005).
Raamsdonk et al. (2001) found that metabolic pathway mutations in yeast
that showed no visual phenotype did, however, have a metabolic phenotype,
demonstrating the usefulness of metabolomics as a phenotyping tool. These
‘silent’ phenotypes have also been identified in C. elegans (Blaise et al.,
2007).
Metabolomic sample preparation (reviewed in Dunn & Ellis, 2005) de-
pends on the platform used, but when profiling intracellular metabolites,
first involves the rapid stopping or ‘quenching’ of enzymatic activity by
quick–freezing or treatment with acid. This is followed by the extraction
of metabolites from frozen, homogenised samples using combinations of
cold solvents, for example, methanol/water, methanol/chloroform/water,
or acetonitrile/water (Lin et al., 2007). An alternative to the analysis of
intracellular metabolites, ‘metabolic footprinting’ involves the analysis of
metabolites excreted by a system, or the ‘exometabolome’ (Kell et al., 2005).
This may involve the analysis of urine, or of microbial growth medium, and
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has been used in metabolomic analysis of C. elegans (Butler et al., 2010;
Martin et al., 2011).
The choice of platform for metabolomics will depend on the level of sen-
sitivity required, the metabolites to be quantified and factors such as ease
of sample preparation. The two main platforms for metabolic profiling are
Nuclear Magnetic Resonance (NMR) Spectroscopy, and Mass Spectrometry
(MS). Proton NMR–based profiling allows the identification and quantifica-
tion of a large number of metabolites across many metabolite classes and
gives a good overview of the metabolome of an organism. NMR also has
the advantage of being non–destructive, and requires only minimal sample
preparation. MS is more sensitive than NMR, able to detect small molecules
in the nanomolar range rather than the millimolar and micromolar range that
can be detected with NMR (Want et al., 2005). However, it is destructive
to samples. Here, both NMR and Gas Chromatography coupled to Mass
Spectrometry (GC–MS) have been used, and are described in more detail
below.
Nuclear Magnetic Resonance
NMR is based on the spin of atomic nuclei, which is determined by the
number of protons and neutrons within the nucleus. An odd number of
protons or neutrons result in an intrinsic magnetic moment and a non–zero
spin (Keeler, 2010). The most common isotope used in NMR spectroscopy
is 1H. In 1H (as well as in 13C and 19F), nuclei have a spin of one half, and
may exist in one of two states, ‘spin–up’ or ‘spin–down’. These states have
the same energy levels and under normal conditions, the number of atoms
in each state will be approximately equal. However, when a magnetic field
35
1 Introduction
is applied, the spins that are orientated with the direction of the magnetic
field will now be at a lower energy level than those spins orientated against
the direction of the magnetic field. At any given time, more nuclei will
populate the lower energy state than the higher energy state (Bothwell &
Griffin, 2010). The proportion of nuclei that exist at each state is determined
by the difference in energy between the two states, and this energy gap is
proportional to the strength of the magnetic field applied. The sensitivity of
NMR spectroscopy depends on the difference in energy states, with higher
magnetic field strengths resulting in greater sensitivity.
Following the polarisation of nuclei in a magnetic field, a pulse of electro-
magnetic radiation at a frequency corresponding to the difference in energy
states is applied. This causes the excitation of nuclei from the lower energy
state to the higher energy state. Following this excitation, nuclei at the
higher energy state begin to return to their lower energy state, in a process
termed ‘relaxation’ (Keeler, 2010). NMR spectra are a result of the energy
released as the nuclei return to their lower energy states. This signal, the
‘Free Induction Decay’ (FID), is made up of signals from the combination of
nuclei in a given sample, each resonating at its own frequency. The signal
decays as the population of nuclei return to their relaxed state. This signal
of intensity vs. time can be Fourier–transformed to give a frequency–domain
NMR spectrum, i.e. intensity vs NMR frequency (Bothwell & Griffin, 2010).
The chemical shift of a nucleus is compared to that of a reference substance
(in hertz) and then divided by the frequency at which the spectrometer
operates (in megahertz). This ratio means that the dimensionless chemical
shift is given in ppm.
36
1.4 Metabolomics
The electrons that orbit each nucleus in a sample shield the nucleus
from the applied magnetic field, so that the overall field experienced by
a nucleus depends on how shielded the nucleus is. This nuclear shielding,
and therefore the resonant frequency of a nucleus, depends on neighbouring
nuclei and their electronic environment. Adjacent nuclei cause peaks to be
split into doublets or triplets and therefore provides information on chemical
structure. The position on the ppm scale, as well as peak splitting, allows
the identification of metabolites. The concentration of a given metabolite
is directly proportional to the total of the integrals of each peak associated
with that metabolite (Keeler, 2010).
An example C. elegans extract NMR spectrum is given in Figure 1.3.
ppm
Figure 1.3: Example NMR spectrum (C. elegans extract).
Gas–Chromatography Mass–Spectrometry
Here, mass–spectrometry coupled to gas–chromatography has been used.
Gas–chromatography provides a way to separate components of a mixed
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sample so that they enter the mass spectrometer sequentially. The GC–
MS is made up of two components: the gas–chromatograph and the mass–
spectrometer (Roessner et al., 2000). The gas–chromatography stage involves
inserting a sample into a capillary column. To improve their volatility,
samples are derivatised prior to injection, in order to decrease the boiling
point of polar molecules. Derivatization accentuates the differences in
the compounds contained within the sample, to aid the chromatographic
separation.
Different molecules within the sample travel at different speeds down this
column, based on their chemical properties, separating them in the process.
The time taken for a given molecule to pass down the capillary is called the
‘retention time’.
Downstream of the gas–chromatograph, the separated molecules enter the
mass spectrometer. Here, compounds undergo ionisation to form ionised
fragments (Want et al., 2007). The ionisation technique used here is Elec-
tron Impact (EI) ionisation, which involves the molecules being bombarded
with free electrons, which causes each molecule to fragment in a charac-
teristic pattern. This is followed by the separation of ions based on their
mass to charge ratio (m/z ). Ions are then detected, in this case by a sin-
gle quadrupole detector, and processed to generate mass spectra. Data
evaluation involves the use of both retention times (generated as a result
of the gas–chromatography step), and fragmentation patterns (from the
mass–spectrometry component).
Gas chromatography is able to provide high resolution chromatograms,
and can differentiate between molecules that have the same retention time.
Different molecules may result in similar mass spectra, and so combining
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these two processes increases the chance that a molecule is identified correctly
(Roessner et al., 2000).
Metabolomic data analysis
The data obtained from metabolomic analysis is multivariate. In order
to examine the relationships between all samples and all variables, it is
necessary to look at all of the data obtained simultaneously by reducing
the data to a few independent summary variables. The thousands of data
points produced by metabolomic analysis can be reduced using multivariate
techniques such as principal component analysis (PCA) (Wold et al., 1987).
This allows us to reduce a large number of possibly correlated variables to
a smaller number of uncorrelated variables or ‘Principal Components’ in
order to obtain an overview of a dataset, and to identify any patterns that
may exist within the data. The first principal component accounts for as
much data variability as possible, the second for as much of the remaining
variability as possible, and so on. Multivariate analysis may be supervised,
where structure in the data is taken into account and separation between
groups is forced, or unsupervised, where no structure in the data is taken
into account. PCA is an example of unsupervised analysis.
In addition to multivariate analysis, it is possible to determine the rela-
tive concentration of individual metabolites within a given sample so that
univariate analysis techniques can be applied. All data analysis techniques
used are described in more detail in Chapter 2.
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1.5 A metabolomic approach for the study of
ageing
It is clear that there is an important link between longevity and ageing,
and metabolism. Additionally, there are many genes that, when mutated,
produce superficially similar effects on lifespan. Using an untargeted /
unselective method for the profiling of low molecular weight metabolites
should provide intermediate phenotypes of ageing and longevity. This may
then be used to determine the functional relationships of target genes as
well as determining those metabolites influencing longevity. An advantage
of metabolomics, is that it allows us to look at changes in metabolites, not
just changes in the genes that control metabolism. This is useful, as a
significant proportion of regulation may occur at the post–transcriptional
or post–translational level. Metabolomics has already been used to study
the effects of ageing. Wang et al. (2007) looked at the effects of ageing
and dietary restriction (DR) on the metabolome of Labradors throughout
their lifetime using the urinary metabolic profiles of both control–fed and
diet–restricted dogs. The results suggested that ageing has a greater effect
on the metabolic profile than does DR. Age related changes have also been
studied in rats (Williams et al., 2005). 1H NMR and HPLC–TOF MS were
used to look at endogenous metabolites excreted in urine.
While some C. elegans metabolic profiling experiments have been carried
out (Blaise et al., 2007; Atherton et al., 2008; Swire et al., 2009; Fuchs et al.,
2010; Martin et al., 2011; Butler et al., 2010; Szeto et al., 2011), at the outset
of this work, no literature existed in this area.
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1.6 Thesis outline
This thesis will examine the usefulness of metabolomics as a new phenotyping
tool for studying life history traits in C. elegans. It begins with the analysis
of an epistatic interaction, using NMR spectroscopy and GC–MS to identify
metabolic phenotypes that are related to longevity. It then investigates the
effects on metabolism of a commonly–used technique in C. elegans ageing re-
search: the inhibition of DNA synthesis to maintain synchronous populations.
These results will then help to control for the use of this technique in the first
characterisation of the C. elegans metabolome throughout both development
and ageing. Comparing the metabolic changes in wild type worms with
those observed in a long–lived mutant should aid the understanding of when
and how mutant worms acquire their long–lived phenotype. Finally, it will
examine the effect of mutation on the C. elegans metabolic profile, with the
first metabolomic study of mutation accumulation.
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2.1 C. elegans strains
Table 2.1 shows the mutant C. elegans strains used. All mutant strains were
obtained from the Caenorhabditis Genetics Centre (http://www.cbs.umn.
edu/CGC/).
Strain name Gene Allele
N2 wild type -
DR1565 daf-2 m41
CB1370 daf-2 e1370
DR26 daf-16 m26
DR1309 daf-2; daf-16 e1370; m26
Table 2.1: C. elegans strains
2.2 Maintenance of C. elegans
2.2.1 Nematode Growth Medium
Nematodes were maintained on Nematode Growth Medium (NGM), con-
sisting of 17 gl-1 agar, 3 g NaCl, 2.5 g peptone, 1 mM CaCl2, 1 mM MgSO4,
25 mM K2HPO4 (pH 6), and 0.1% cholesterol. Cholesterol was dissolved in
ethanol, filter–sterilised and added after sterilising the remaining mixture in
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an autoclave. Approximately 20 ml of the liquid NGM was poured into each
90 mM diameter Petri dish and once set, plates were seeded with E. coli
strain OP50 as a food source.
For fluorodeoxyuridine (FUdR) plates, FUdR was dissolved in water,
filter–sterilised and added to the liquid NGM after autoclaving to give a
final concentration of 100 mgl-1.
Where required, worms were transferred to plates containing FUdR at
young adulthood. Worms were washed from plates using M9 buffer (22 mM
KH2PO4, 42 mM Na2HPO4, 85.5 mM NaCl, 1 mM MgSO4) into 15 ml cen-
trifuge tubes and allowed to settle naturally for 3 minutes before the majority
of the supernatant was removed. The remaining suspension of worms was
then pipetted onto seeded FUdR plates.
2.2.2 OP50 food source
E. coli OP50 is a uracil auxotroph which prevents overgrowth of the bacterial
lawn. The OP50 was cultured overnight in 10 ml of Luria broth and then
stored at 4 ℃ until use. To seed plates with bacteria, 200 ml of the OP50
culture was added to each plate and spread with a sterile, L–shaped spreader.
Plates were incubated overnight at 37 ℃ before use.
As FUdR prevents all DNA synthesis, E. coli is not able to proliferate
on NGM containing FUdR. For this reason, an overnight E. coli culture
was concentrated by a factor of 50 before aliquots were spread on NGM
containing FUdR, as described by Mitchell et al. (1979). These seeded
plates were then incubated overnight at 37℃ and this resulted in a lawn of
E. coli.
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2.2.3 Egg preparation
To obtain age–synchronised populations, gravid adults were washed from
plates with M9 buffer into 15 ml centrifuge tubes and centrifuged at 1300 g
for 1 minute before the supernatant was removed. Bleaching solution (20%
NaOCl (4%), 5% 10 M NaOH ) was added to the pellet and the tubes
shaken well at regular intervals for a total of 10 minutes. The tubes were
then centrifuged at 1300 g for 1 minute and the supernatant removed. M9
buffer was used to wash the pellet (centrifugation followed by removal of
the supernatant). The pellet was then resuspended in 0.1 ml M9 buffer, and
transferred to a clean NGM plate seeded with E. coli OP50. This method
leaves only those worms protected by the egg shell.
2.3 C. elegans longevity assays
Synchronised populations of L4 larvae were grown at a density of ten worms
per plate. During the egg–laying period, worms were transferred to new
plates daily, so that the original population could be separated from their
progeny. When all strains had ceased to lay eggs, worms were transferred to
new plates every two days. Worms were scored as dead with the absence of
movement and the failure to respond to several light pokes with a platinum
wire, as described by Gems et al. (1998). The number of surviving worms,
cumulative number of dead worms, and missing worms per plate were
recorded at each transfer point. Missing worms, and deaths occurring as a
result of internal hatching of progeny, were recorded as censored data.
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2.4 Preparation of C. elegans for metabolomic
analysis
2.4.1 Harvesting C. elegans
Worms were washed into sterile, 15 ml screw–capped tubes from plates with
M9 buffer, allowed to settle at the bottom of the tube for 1 minute, and
the supernatant removed. The resulting pellets were transferred to 2 ml
microcentrifuge tubes and immediately snap–frozen in liquid nitrogen to
quench metabolism. Samples were then stored at -80℃ until use.
Where older adult worms were required (except where the use of FUdR
prevented the production of progeny) their offspring were removed by re-
peated filtering using 50µm Nitex membranes (Sefar Ltd., Bury, UK). Worms
were washed from agar plates using M9 buffer, and the resulting suspension
filtered using the 50µm membrane. The larger, older worms were retained
by the membrane, and were transferred to new agar plates by gently pressing
the membrane onto fresh plates. This process was then repeated to ensure
all small, young worms were removed.
2.4.2 Extraction of metabolites
In Chapters 3 and 4, each 0.5 ml frozen pellet was ground using a liquid
nitrogen–cooled pestle and mortar before the addition of 2 ml 100% methanol,
resulting in an overall methanol concentration of approximately 80%. After
further grinding, the sample was pipetted into a microcentrifuge tube. The
pestle and mortar were washed with 2 ml 80% methanol, which was trans-
ferred to a second tube. All extraction solvents used were ice–cold. The
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tubes were incubated on ice for 10 minutes and then centrifuged for 5 min-
utes at 13000g. The supernatants were then combined and vacuum–dried
overnight.
In Chapters 5 and 6, worms were transferred to in 2 ml tubes containing a
0.3 ml volume of 0.1 mM diameter SiO2 beads before being snap–frozen. For
extraction, 1.2 ml 100% methanol was added to each tube containing a 0.3 ml
worm pellet, and a Precellys 24–Dual bead beater (Bertin Technologies) was
used to homogenise the samples, operated at 6500 rpm for 60 seconds. This
process was repeated with an 80% methanol wash. Again, all extraction
solvents used were ice–cold. After centrifugation for for 5 minutes at 13000 g,
supernatants from the two steps were combined and transferred to new tubes
and vacuum–dried overnight.
2.5 NMR spectroscopy
2.5.1 Sample preparation
650µl NMR buffer (95% 2H2O, 0.1 M phosphate buffer, pH 7.0, 0.97 mM
trimethylsilyl propanoic acid (TSP)) was added to each dried–down sample,
sonicated for 1 minute and then centrifuged for 10 minutes at 16000 g. 600µl
of the supernatant was transferred into an NMR tube.
2.5.2 Data acquisition
NMR spectra were acquired essentially as described by Beckonert et al.
(2007) using a Bruker Avance DRX600 spectrometer with a 14 T magnet,
equipped with a 5 mm cryogenically cooled inverse probe. However, for life
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cycle data (Chapter 5), a Bruker Avance II 800 spectrometer, equipped with
a triple–resonance cryoprobe was used.
Typically, spectra were acquired over a 12 kHz spectral width into 32K
data points, using a 1D NOESY pulse sequence for improved baseline shape
over a simple presaturation experiment. Eight dummy scans and from 256
to 512 scans were acquired per free induction decay (FID). An additional
3.5 s relaxation recovery delay was included per scan, giving a total recycle
time of 5 s.
2.5.3 Data processing
The spectra were processed in iNMR 2 (http://www.inmr.net), using
1.5 fold zero filling and an exponential apodization factor of 0.5 to 1 Hz.
Following Fourier transformation, the spectra were corrected for phase, the
TSP peak referenced to 0 ppm, and a first–order polynomial fitted to the
baseline, using the software proprietary algorithms. Individual spectra were
corrected manually if necessary. The integrate function was used to set
manual bins such that all resonances were, as far as possible, assigned to a
single bin, and no bins contained only noise across all spectra.
Individual metabolites were identified and quantified using Chenomx
NMR Suite 5.0 (Chenomx, Edmonton, Canada). This software aids the
identification of compounds based on a database of standards, and allows
the concentrations of these metabolites to be calculated, using an internal
standard of known concentration (here, TSP).
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2.6 Gas chromatography mass spectrometry
2.6.1 Sample preparation
20µl quantitation standard mixture (1.5 mM 2,2,3-d3-leucine, 1.3 mM 13C-
[U]-glucose) was added to each extracted sample before vacuum–drying in
Agilent 2 ml autosampler vials. Samples were derivatized using silylation,
to produce silyl derivatives (active hydrogens are replaced with a TMS
trimethylsilyl group) which are more volatile, less stable, and more thermally
stable. Derivatization was carried out as described by Lisec et al. (2006):
40µl Methoxyamine hydrochloride (20 mgml-1 in pyridine) was added to
each tube and the samples were incubated at 37℃ for 2 hours with shaking.
Following incubation, 70µl N-Methyl-N-(trimethylsilyl)trifluoroacetamide
(MSTFA) and 10µl injection standard (2-fluorobiphenyl) was added to each
tube. This was followed by a further incubation period of 30 minutes at
37℃ with shaking.
2.6.2 Data acquisition
Samples were analysed on an Agilent 5975c quadrupole mass spectrometer
with a 7890 gas chromatograph, equipped with a 30 m x 0.25 mm HP–5ms
column, and splitless injector. The method was based on that described by
Lisec et al. (2006). The injector port was heated to 230 ℃ and the source
to 200 ℃. Carrier gas was helium (1 ml min-1). 1µl of sample was injected,
using the following temperature program: isothermal at 70 ℃ for 5 minutes,
followed by a 5 ℃/min ramp to 230 ℃, followed by a 10 ℃/min ramp to 330
℃, and isothermal for 5 minutes. The mass spectrometer was set to scan
from 50–600 Da at 5,000 Da/s.
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2.6.3 Data processing
Metabolites were identified using the Fiehn Library (Kind et al., 2009)
and AMDIS, a deconvolution programme (Stein, 1999). Validation of this
identification and peak integration for quantification was then carried out
using the GAVIN script for Matlab (Behrends et al., 2011)
2.7 Data analysis
2.7.1 Survival analysis
Kaplan–Meier analysis (Bland & Altman, 1998) was performed on survival
data to generate survival curves using Aabel v3 (Gigawiz Ltd. Co.). This
method allows for censored data, and therefore takes into account data
associated with missing worms, or with death due to internal hatching of
progeny.
2.7.2 Data normalisation
Processed data were normalised following the method of Dieterle et al. (2006),
in which all spectra are compared to a reference spectrum, as before, using
the median fold change across all variables. Normalisation was carried out
using Microsoft Excel for Mac v12.2.9.
2.7.3 General statistical analyses
Linear regressions were carried out using Aabel v3 (Gigawiz Ltd. Co.). Linear
regressions are OLS (ordinary least squares) regressions unless otherwise
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stated. In some cases a Reduced Major Axis (RMA) regression has been
used. An RMA regression may be of use when the direction of causality
between variables (i.e. which variable is independent and which is dependent)
is not known (Smith, 2009).
T–tests were carried out using Microsoft Excel for Mac v12.2.9, and
correlation matrices (Spearman’s rank correlation coefficient and associated
p–values) were generated in MATLAB (R2010b, The Mathswork Inc.).
2.7.4 Multivariate analysis
All multivariate analyses were carried out using SIMCA-P+ v12.0.1 (Umet-
rics), with figures generated using Aabel v3 (Gigawiz Ltd. Co.).
Unsupervised analysis
The unsupervised multivariate analysis used was Principal Component Anal-
ysis (PCA), as described by Wold et al. (1987). PCA reduces the dimension-
ality of a dataset by generating a set of uncorrelated variables (principal
components) from a set of correlated variables. Each principal component
explains less of the total variance in the data than the previous component.
PCA results in a matrix of scores, summarising the original variables, and a
matrix of loadings, showing the relative influence of each variable. Together,
the scores and loadings for a given component show which variables are re-
sponsible for any patterns observed in the data. The number of components
fitted in a model is determined by cross validation to test the significance of
each principal component.
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For each analysis, the total amount of variance explained by the model
is given by R2 and is quoted either for individual components or as a
cumulative value, taking into account all fitted principal components. The
cumulative cross validated goodness of fit statistic across all components,
Q2 (cumulative), is also given for each model, and provides an estimate
of how well the model would be able to describe additional data. This
makes it possible to judge whether the model is specific to the current
data, or could adequately describe new samples, i.e., whether the model is
over–fitted.
Supervised analysis
The supervised analysis methods used were Partial Least–Squares Regression
(PLS) and PLS–Discriminant Analysis (PLS–DA) as well as Orthogonal–PLS
(OPLS) and Orthogonal PLS–Discriminant Analysis (PLS–DA).
PLS regression, described by Wold et al. (2001), is used to find the
relationship between two matrices, X and Y, where the X matrix contains
predictive variables and the Y matrix contains dependent variables. PLS
modelling aims to maximise the correlation between these matrices by
projecting the predictor variables and the observable variables to a new
space and generating latent variables that are maximally associated with
the Y variable. PLS regression is well suited to datasets where the X
matrix contains more variables than observations. PLS–DA is used when
the Y variable groups the data into one of two groups (i.e. is binary).
OPLS (Trygg, 2002) is a modification of PLS, removing variation in the X
matrix that is orthogonal to Y, and therefore unrelated to Y. This results
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in a predictive component (variation that is linearly related to Y) and an
orthogonal component (orthogonal to Y).
Model statistics are given for each analysis. The total amount of variance
explained by the model is given by R2(cumulative), with R2X and R2Y rep-
resenting the X and Y matrices respectively. For PLS models, Q2 estimates
the ability of the model to predict an unknown Y, given the corresponding
X variables. As with PCA, a large Q2 value indicates the model is not
over–fitted.
Cross validation determines the number of significant PLS components
fitted in a model. A subset of observations are removed from the model, so
that Y values for this subset are predicted by the model. These predicted
values are compared with the true values. This is repeated so that each
observation has been included in the removed subset once.
Figure 2.1: Validation of an OPLS regression model, from section 5.2.
All PLS models were validated using permutation analysis (Lindgren et al.,
1996). Permutation analysis randomises the pairings of the X and Y matrices,
generating a model in which there is no true relationship between X and
Y. For each permutation of the Y vector, a model is generated with the
same number of components as the model to be validated. Q2 statistics
are generated for each of these models, resulting in a distribution of Q2
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values, for models where X and Y are unrelated. The cumulative Q2 value
associated with the model to be validated should be clearly distinct from
the randomised distribution of Q2 values. Figure 2.1 shows the result of this
analysis for the OPLS model generated in section 5.2. In this case, and in all
other PLS or OPLS models presented, the actual Q2 value is clearly distinct
from and greater than the overall randomised Q2 distribution.
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3.1 Introduction
While some literature on the subject now exists (Blaise et al., 2007; Ather-
ton et al., 2008; Swire et al., 2009), the use of metabolomics to study
C. elegans is still relatively untested and at the outset of this analysis, no
metabolomic analysis of C. elegans had been published. To demonstrate
that a metabolomic approach may be used to analyse C. elegans longevity
mutants, 1H NMR spectroscopy was used to obtain metabolic profiles for wild
type and daf-2(m41) worms. The m41 mutation is a hypomorph mutation
that disrupts daf-2, which encodes a tyrosine kinase expressed throughout the
worm that acts as a receptor for many of the 37 insulin–like ligands present
in the C. elegans genome (Li et al., 2003; Pierce et al., 2001). Its mutation
results in the nuclear localisation of DAF-16, which encodes a FOXO tran-
scription factor, leading to changes in expression of many longevity–linked
genes (Lee et al., 2003b; Libina et al., 2003; Lin et al., 2001).
The mutation of one gene that masks the phenotypic effects of a mutation
of another gene is referred to as an epistatic interaction. The long–lived
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phenotype of C. elegans IIS mutants (such as daf-2 mutants) is repressed
by a null mutation in daf-16. It may be the case that daf-2 mutants show
phenotypes that are unrelated to their increased longevity. Phenotypes at
the metabolite level that are linked with an increase in life span should not
be seen when DAF-16 activity is inhibited. This idea has previously been
applied to both transcriptomic and proteomic data (Murphy et al., 2003;
Dong et al., 2007). In order to establish whether the observed metabolic
changes are also DAF-16 repressible, the metabolic profiles of a different
hypomorph daf-2 mutant (daf-2(e1370))) a daf-16 mutant (daf-16(m26)),
the associated double mutant (daf-2(e1370);daf-16(m26)) and a wild type
control (N2) were compared using both 1H NMR spectroscopy and Gas
Chromatography–Mass Spectrometry (GC–MS).
3.2 Results
3.2.1 Metabolomic analysis of a long–lived mutant
After confirming the increased longevity of daf-2(m41) worms relative to wild
type worms via a longevity assay of a population of 100 worms of each strain
(Figure 3.1 A), NMR spectroscopy was used to obtain the metabolic profiles
of 10–day–old wild type and daf-2(m41) worms grown at 15℃ until the L4
stage, when the incubation temperature was increased to 22.5℃.
To ensure that only old worms were sampled at this point, their offspring
were removed regularly by repeated filtering using 50µm Nitex membranes
as described in Chapter 2. At ten days post hatching, worms were washed
from plates with M9 buffer and quick–frozen in liquid nitrogen. Samples
were stored at -80℃ before extraction with 80% methanol and analysis by
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Figure 3.1: Survival analysis of: (A) daf-2(m41) and wild type worms (N2) and
(B) mutants used in epistasis experiment: daf-2(e1370), daf-16(m26), double mutant
daf-2(e1370);daf-16(m26) and wild type (N2).
NMR spectroscopy. Spectra were manually binned as described in Chapter 2
and the resulting data normalised using median fold change normalisation.
As the aim of this study was only to determine whether a clear difference
between strains could be seen, at this point, identification of metabolites
was not important.
Principal Component Analysis (PCA) of log transformed data resulted in
a three component model, where the first three Principal Components (PCs)
explain 50, 11 and 7% of the variance respectively. The two strains are
clearly separable on PC1 and hierarchical cluster analysis (HCA) confirms
the presence of two groups: one containing mostly wild type samples and
the other containing mostly mutant worms (Figure 3.2 A). The relative
concentrations and loadings for bins with the most substantial loadings
(>0.1 and <-0.1, 34 bins of a total of 179) on PC1 are shown in Figure 3.2
B. The positions of these bins are also shown.
The relative concentrations of 26 metabolites were determined in wild
type and daf-2(m41) worms as described in Chapter 2. Of these, 15 differed
significantly between strains (two–tailed t–test, p < 0.05, Figure 3.3). The
daf-2(m41) mutants had elevated levels of alanine, succinate, choline, tre-
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Figure 3.2: A. 1H NMR spectroscopy followed by principal component analysis
demonstrates that daf-2(m41) and wild type worms have distinct metabolic profiles
and are clearly separable along PC1 (means and 95% CI are given by ellipses). In the
three component model, the first three PCs explain 50, 11 and 7% of the variance
respectively and the two strains can be clearly separated on PC1. Hierarchical cluster
analysis separates the samples into two groups, one containing mostly wild type worm
samples and the other containing mostly mutant worm samples. B. The spectrum
shows the median of five N2 samples, with intensities >5.0 ppm scaled by a factor of
10. The heat map shows the relative concentration of 34 bins out of a total of 179
with a substantial (>0.1 and <-0.1) loading on PC 1, their position on the spectrum
(above) and their loadings (below).
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Figure 3.3: Mean levels of individual metabolites in wild type and daf-2 worms. The
concentrations of all metabolites shown differed significantly (p<0.5) between strains.
Error bars represent the standard error of the mean for each metabolite.
halose, lactate, nicotinate, phenylalanine and tryptophan, and decreased
levels of glutamate, formate, phosphocholine, malate, NAD+, aspartate and
betaine relative to wild type worms. However, a Bonferroni correction to
correct for multiple comparisons gave an adjusted significance level of 0.002.
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Using this corrected value, aspartate, lactate, glutamate, betaine, succinate,
nicotinate, alanine, and NAD+ were still found to differ significantly between
the strains.
3.2.2 Metabolomic analysis of an epistatic interaction
Longevity analysis of all strains gave the expected results, with daf-2 worms
having a greater mean life span than all other strains, and both daf-16
and daf-2;daf-16 mutants showing approximately wild type longevity (Fig-
ure 3.1 B). These results confirmed that the daf-2–induced lifespan extension
was fully DAF-16 repressible under the conditions of this laboratory. For
metabolomic analysis, synchronised populations were grown at 15℃ on NGM
plates until the L4 stage, when the incubation temperature was increased
to 22.5℃. At six days post hatching, all strains were washed from plates
with M9 buffer and quick–frozen in liquid nitrogen, following filtration using
50µm Nitex membranes to ensure that only old worms were sampled (as
described in Chapter 2). Samples were stored at -80℃ before extraction
with 80% methanol. From each sample, 20% of the total extraction volume
was stored for analysis with GC–MS and the remainder used for analysis
by NMR spectroscopy. GC–MS is more sensitive than NMR spectroscopy
and therefore requires less biomass (in this case fewer worms) per sample.
This further analysis of the samples also gives a greater coverage of the
metabolome than NMR alone.
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Figure 3.4: The metabolomes of daf-2 worms, daf-16 worms, double mutant (daf-
2;daf-16) worms and wild type worms were compared using 1H NMR spectroscopy. PCA
and cluster analysis divide the samples into two main groups. One cluster contains the
daf-2 worms, and another cluster contains the other three strains. The first 3 principal
components explain 31, 21 and 13% of the variance respectively.
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Analysis by 1H NMR spectroscopy 1
All spectra were manually binned and then normalised using median fold
change normalisation. Principal component analysis (a three component
model where the first three principal components explain 31, 21 and 13%
of the total variance respectively) and HCA of log transformed data divide
the samples into two main groups; one cluster contains the daf-2 worms,
and another cluster contains the other three strains (Figure 3.4). While
this demonstrates that the metabolic phenotype of daf-2 worms at least
partially depends on DAF-16, there is clearly some structure within the
cluster containing wild type, daf-16 and double mutant worms. Double
mutants form a sub–cluster clearly distinct from wild type worms, implying
that not all of the daf-2 phenotype is DAF-16 dependent.
For each sample, forty metabolites were identified and quantified. Analysis
of the pattern of change of 11 metabolites found to vary in daf-2(e1370)
mutants compared to wild type showed that only four – isoleucine, valine,
leucine and phosphocholine – follow the classic pattern of DAF-16 depen-
dence. That is, the relative concentrations of each of these metabolites
were significantly elevated or reduced (p <0.05) in daf-2(e1370) mutants
but not in daf-16 mutants or double mutant worms (Figure 3.5). Other
metabolites showed more complex patterns of epistasis. For example, relative
concentrations of lysine, lactate and glycerol were all significantly different
in both daf-16 worms and double mutants compared with wild type worms
(p <0.05; two–tailed t–test). Additionally, while daf-16 mutants have wild
type levels of trehalose, the relative concentration of the sugar in double
mutants was no different to that observed in daf-2 mutant worms.
1Experimental data obtained jointly with Jonathan Viney, Imperial College.
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Figure 3.5: Analysis of the levels of 11 metabolites found to vary in daf-2(e1370)
mutants compared to wild type showed that only four – isoleucine, valine, leucine and
phosphocholine – follow the classic pattern of DAF-16 dependence. That is, the relative
concentrations of each of these metabolites were significantly elevated or reduced (p
<0.05) in daf-2(e1370) mutants but not in daf-16 mutants or double mutant worms.
Other metabolites showed more complex patterns of epistasis. Error bars indicate one
standard deviation from the mean.
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Analysis by Gas Chromatography Mass Spectrometry
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Figure 3.6: Partial least squares discriminant analysis (three component model, R2X
(cumulative) = 0.433, R2Y (cumulative) = 0.719, Q2 (cumulative) = 0.517) divides
the samples into the two groups seen in the NMR dataset. One large cluster contains
daf-2(e1370) worms, and another cluster contains the other three strains. These two
clusters are separated on the second component.
Metabolites were identified based on their retention time and mass spec-
trum and then quantified (as described in Chapter 2), giving a total of
148 metabolites that were used for subsequent data analysis. These data
were normalised using median fold change normalisation and scaled to unit
variance. While PCA using NMR data showed clear separation between
groups, the larger number of variables identified by GC–MS and possible
higher variability resulted in poor discrimination between groups by PCA for
GC–MS data. However, a supervised analysis, Partial Least Squares Discrim-
inant Analysis (PLS–DA), of log transformed data, gives good separation
between groups (Figure 3.6). PLS–DA (a three component model, R2X
(cumulative) = 0.433, R2Y (cumulative) = 0.719, Q2 (cumulative) = 0.517),
where each strain is given a different class, divides the samples into the two
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Figure 3.7: Loadings corresponding to the PLS–DA scores in Figure 3.6. Only the
first two components are shown.
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Figure 3.8: Again, leucine and valine show DAF-16 dependence, as does dopamine,
which was undetected by NMR spectroscopy. As before, trehalose appears to be DAF-16
independent, and succinate shows a more complex pattern of epistasis consistent with
the pattern seen in the NMR data. In the notched box and whisker plots, whiskers
are extended to the extreme data points, and the box spans the distance between the
two quartiles surrounding the median. The width of a notch is proportional to the
interquartile range of the sample, and inversely proportional to the square root of the
number of samples. Where there is no overlap between the notches of two boxed, the
medians of the two groups are significantly different.
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groups seen in the NMR dataset. One large cluster contains daf-2(e1370)
worms, and another cluster contains the other three strains. These two
clusters are separated on the second component. As with the NMR dataset,
some structure can be seen in the wild type, daf-16, double mutant cluster.
Figure 3.7 shows the loadings for the first two components.
A two–way ANOVA, where the factors one and two were defined as
daf-2 and daf-16 respectively, identified those metabolites whose relative
concentrations were significantly different (p <0.05) in daf-2 worms only. Of
the 148 metabolites found to be present in the samples, seven showed classical
DAF-16 dependence in this way. These were adenosine, citrate, dopamine,
leucine, valine, phenylalanine and putrescine. A selection of these are shown
in Figure 3.8 along with trehalose and succinate. As before, trehalose appears
to be DAF-16 independent, and succinate shows a more complex pattern of
epistasis consistent with the pattern seen in the NMR data. Leucine and
valine once again show DAF-16 dependence (although isoleucine does not)
and dopamine, putrescine, adenosine, citrate and phenylalanine have been
identified as additional potential metabolites that may play a role in the
ageing process.
3.3 Discussion
The comparison of the metabolic profile of wild type worms with that of
long–lived mutant daf-2(m41) was a proof–of–principle experiment that has
demonstrated that untargeted metabolic profiling using NMR spectroscopy
was sensitive enough to detect differences between these strains. This also
provided confirmation that the metabolome of this long–lived strain differed
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from that of wild type worms. A wide range of metabolites could be detected
in the tissue extracts, including amino acids, aromatic compounds and
sugars. Analysis of an epistasis interaction showed that metabolomics is a
good tool for identifying metabolic changes associated with long life. These
experiments have also shown that both NMR spectroscopy and GC–MS
are suitable platforms for C. elegans metabolomics studies, with GC–MS
supporting many of the findings made using NMR as well as allowing the
identification of additional metabolites.
The initial analysis, using daf-2(m41) mutants, identified several metabo-
lites that change in this long lived strain relative to wild type. For example,
in daf-2(m41) worms, trehalose levels were found to be elevated relative to
wild type. This disaccharide is important in nematodes as a carbohydrate
storage molecule, and is thought to confer stress resistance in many inverte-
brates, protecting lipids and proteins from desiccation or freezing damage
(Behm, 1997; Pellerone et al., 2003). It has been suggested that trehalose is a
‘longevity assurance sugar’ and the genes involved in its synthesis are known
to be up–regulated in IIS mutants (Lamitina & Strange, 2005; McElwee
et al., 2006). Other metabolites with altered levels in daf-2(m41) such as
malate and succinate, which are associated with carbohydrate metabolism,
and choline, which is involved in lipid metabolism, may be further signatures
of longevity.
Unsupervised multivariate analysis of the epistasis NMR data divides the
samples into two main groups; one containing the daf-2 mutants and the
other containing all other strains (daf-16 worms, double mutants and wild
type worms). There is, however, some structure within the wild type, daf-16,
double mutant cluster, with double mutants clearly separable from wild
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type worms. While the long–lived phenotype of daf-2 mutants is DAF-16
repressible, other daf-2 related phenotypes at the metabolic level clearly are
not. Those metabolites found to show classical DAF-16 dependence may
therefore have a causal role in making worms long–lived. Equally, those
found not to be DAF-16 dependent may not contribute to long life. Trehalose
has been found in increased concentrations in age-1 mutants, daf-2 mutants
and dauers (Lamitina & Strange, 2005; McElwee et al., 2006), as well as
the two long–lived mutants studied here. However, these results suggest
that trehalose levels are not DAF-16 dependent, and this is in contrast to
previous studies. Two of the genes upregulated by DAF-16 are tps-1 and
tps-2 (McElwee et al., 2003; Murphy et al., 2003). These encode trehalose-6-
phosphate synthase, which is responsible for the biosynthesis of trehalose.
However, differences in gene expression may not always reflect functional
changes, which may explain this contradiction. Trehalose treatment has
been found to increase longevity and slow ageing in wild type C. elegans
and in daf-2; daf-16 double mutants but not in daf-2 mutants, suggesting
that treatment with trehalose and daf-2 mutation extend lifespan via a
common mechanism (Honda et al., 2010). The lifespan extension of a daf-16
null mutant, however, suggests that an increase in longevity resulting from
trehalose treatment does not require DAF-16, which is consistent with the
metabolomic data. While often thought to be an important metabolite for
longevity, the DAF-16 independence seen in trehalose levels (in both NMR
and GC–MS data) suggests that daf-2 may regulate this metabolite via a
transcription factor that acts parallel to DAF-16.
NMR analysis suggests the branched–chain amino acids, isoleucine, leucine
and valine are all DAF-16 repressible, with significantly increased levels in
daf-2(e1370) mutants compared with all other strains (p<0.5). Martin et al.
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(2011) also found high levels of BCAAs in daf-2(e1370) worms, along with
altered transcript levels of genes involved in BCAA metabolism compared
with wild type. Again, these changes were found to be DAF-16 repressible.
This result is consistent with the findings that not only do branched–chain
amino acids (BCAAs) extend the chronological lifespan of yeast (Alvers
et al., 2009), but that mice given a diet supplemented with BCAAs have an
increased lifespan relative to control mice (D’antona et al., 2010). Here the
authors show that mice fed the BCAA supplement long term had increased
mitochondrial biogenesis in cardiac and skeletal muscles, increased SIRT1
expression, and decreased oxidative damage to an increase in expression of
ROS defence genes in muscle. BCAA supplements have also been shown to
improve age related disorders in rats (Pansarasa et al., 2008) and in humans
(Solerte et al., 2008a,b), improving age–related disorders such as sarcopenia
(a loss of muscle mass, function and strength with age), insulin resistance
and type 2 diabetes. D’antona et al. (2010) also showed that the increase in
mitochondrial biogenesis and increased expression of ROS defence genes due
to BCAA supplementation was induced by increased expression of endothelial
nitric oxide synthase (eNOS), as is the case with increased mitochondrial
biogenesis and increased ROS defence due to caloric restriction. Isoleucine,
leucine and valine were also all slightly elevated relative to wild type in
10–day old daf-2(m41) worms (an increase of 9, 4 and 19% respectively), but
this difference was not significant at the 95% significance level (p = 0.35,0.57
and 0.08 for isoleucine, leucine and valine respectively). It may be the case
that the degree to which these metabolite levels change with mutation of
daf-2 may depend on the allele studied, or possibly sampling age.
Another metabolite that appears to be DAF-16 repressible and is therefore
potentially associated with longevity is phosphocholine, which is found
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in significantly reduced concentration in daf-2(e1370) worms compared
with the other epistasis strains as well as being found at significantly lower
concentration in daf-2(m41) worms than wild type worms. Phosphocholine is
a precursor of phosphatidylcholine, a phospholipid present in cell membrane
bilayers and therefore it is possible that reduced phosphocholine is a result
of reduced cell turnover. Phosphocholine is found in high concentration in
dauer larvae (Swire et al., 2009), but dauers do not feed and therefore rely
on internal energy resources for survival and as a breakdown product of
phosphatidylcholine, phosphocholine levels may increase if lipid metabolism
is increased. Unlike dauers, daf-2 worms are able to feed, and therefore do
not need to metabolise energy stores, so that phosphocholine levels remain
low. Both the BCAAs and phosphocholine have been shown to follow a
similar pattern (increases in BCAAs and a decrease in phosphocholine) in
other long–lived worms (Fuchs et al., 2010).
Many results from GC–MS analysis are consistent with NMR analysis.
For example, once again, the branched–chain amino acids leucine and valine
were identified as DAF-16 repressible. One metabolite that could not be
identified using NMR but was seen in GC–MS analysis and found to be
DAF-16 repressible is dopamine. Dopamine mediates the ‘basal slowing
response’ in C. elegans. This is the slowing of movement on encountering
food, and worms that are unable to produce dopamine fail to slow in response
to food (Sawin et al., 2000). The results are consistent with those of Gaglia
& Kenyon (2009), who found that the dopamine system is altered in daf-2
worms and that the changes seen in response to dopamine in the environment
are linked with DAF-16 activity in neurons.
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Putrescine, phenylalanine, adenosine and citrate were all found at lower
concentrations in daf-2 worms than in the other epistasis strains. Changes in
pools of phenylalanine are consistent with the fact that many genes encoding
components of the catabolic pathways of phenylalanine are regulated in
daf-2 worms (Dong et al., 2007; Fisher et al., 2008). Putrescine is a product
of amino acid breakdown, suggesting that this process may be inhibited in
some way in daf-2 worms.
Some metabolites showed more complex patterns of epistasis. Relative
concentrations of lysine, lactate and glycerol were all significantly different
in both daf-16 worms and double mutants compared with wild type worms
(p <0.05; two–tailed t–test). The complex patterns of epistasis seen in
these metabolites are more difficult to interpret. Daf-16(0) null mutants
show several subtle phenotypes such as rapid growth, early reproduction
and slightly reduced longevity compared to wild type worms. In addition
to this, at least some DAF-16 can be detected in the nuclei of wild type
worms (Cypser & Johnson, 2003; Weinkove et al., 2006). This suggests that
the model of DAF-16 being fully repressed in wild type worms and then
activated in daf-2 mutants is too simple and it appears that some metabolite
levels may be sensitive to even very low levels of DAF-16 activity.
Conclusion
It is possible to distinguish between long–lived daf-2 mutants and wild type
C. elegans based on metabolic profile. Metabolomics has therefore been
shown to provide a new and useful phenotyping tool for studying C. elegans
ageing and longevity. Both NMR spectroscopy and Gas Chromatography–
Mass Spectrometry are good platforms for this analysis, with the more
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sensitive GC–MS supporting many of the findings made with NMR as well
as allowing the identification of additional metabolites. The analysis of
an epistatic interaction using metabolomics is a useful way to help focus
future research. While the long–lived phenotype of daf-2 mutants is DAF-16
repressible, it is clear that other daf-2 related phenotypes are not; those
metabolites found to show classical DAF-16 dependence may have a causal
role in making worms long–lived. Equally, those found not to be DAF-16
dependent may not contribute to long life.
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4 The Effect of
5-fluoro-2-deoxyuridine on the
C. elegans Metabolome
4.1 Introduction
A common problem encountered when analysing ageing in C. elegans is that
of separating adult worms from their progeny. Under optimal conditions,
worms begin to reproduce at around 3 days post–hatching and egg laying
continues over a several day period. This means that to obtain a synchronous
population of ageing adults, new progeny should be separated from parents
before the point at which they can no longer be distinguished from older
worms, ensuring that multiple generations are not mixed. If only very small
numbers of ageing worms are required, it is possible to regularly transfer
individual worms to new plates during the egg–laying period. However, this
is not feasible if large numbers of worms are required. For this reason, it
is helpful if the worms to be analysed are sterile, so that no progeny are
produced and the population remains synchronous for the entire lifespan
of the worms. There are two common methods of creating sterile worms
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– the use of fertility mutations (e.g. using fer– mutants) or the use of the
chemical 5-fluoro-2-deoxyuridine (FUdR).
Fertility mutants
Fer– mutants produce the normal number of eggs and sperm, but are
defective in some sperm–specific function required for normal fertilisation
– in males, sterility may be due to either defective sperm, or an inability
to transfer sperm during copulation – so that fertilised eggs are very rare
(Argon & Ward, 1980). Fer– mutants grow and develop like wild–type worms,
and egg–laying occurs at the normal time. Fertilisation–defective mutants
have been used previously in microarray analysis of ageing in C. elegans.
Murphy et al. (2003) used RNA interference (RNAi) to reduce daf-2 and
daf-16 activity, followed by microarray analysis to identify genes with altered
expression in these strains. However, instead of using wild type worms, a
sterile strain (fer-15(bn26);fem-1(hc17)) was subjected to RNAi, so that a
population of developmentally synchronous worms was easily obtained. Age–
related changes in gene expression were generally no different in daf-2(RNAi)
and daf-16(RNAi);daf-2(RNAi) animals, which is surprising, as the daf-16
mutation suppresses the longevity–enhancing effects of the daf-2 mutation.
While this unexpected result might be due to an effect of the RNAi itself,
the consequences of using sterile worms should also be considered. Similarly,
Halaschek-Wiener (2005) used serial analysis of gene expression (SAGE) to
analyse the transcriptome of the long–lived mutant daf-2(m41). However,
the daf-2 mutant also carried a temperature–sensitive fer-15 mutation to
prevent the production of offspring, and a fer-15 mutant was used as a
control. While the life span of fer-15 worms was found to be not significantly
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different from N2 (wild type) worms (fer-15 mutants had a maximum life
span of 22 days compared with an N2 life span of 20 days), it is possible that
the fer-15 mutation may have concealed transcriptional differences between
the long–lived daf-2 mutant and wild type worms.
5-fluoro-2-deoxyuridine
Growing C. elegans on 5-fluoro-2-deoxyuridine inhibits DNA synthesis
(Mitchell et al., 1979). As the only mitotic activity in adult C. elegans
is in the germ line, this, in theory, only affects egg production, killing larvae
but not adults. Eliminating egg production in this way has been found not
to significantly affect the life span of worms grown under standard conditions
(Apfeld & Kenyon, 1998; Hosono et al., 1982), although a slight increase
(7%) in lifespan has been reported (Mitchell et al., 1979). It is thought that
changes in the ageing process remain qualitatively unchanged (Yasuda et al.,
2006; Mitchell et al., 1979).
Like fertilisation mutants, FUdR is often used where populations of syn-
chronous, ageing adults are required (Shaw et al., 2007; Houthoofd et al.,
2002; Lee et al., 2003a) and in longevity assays, so that daily transfer of
worms to new plates during the reproductive period is not required. While
FUdR is regularly used in studies on ageing, FUdR–treated animals survive
longer in the presence of a pathogen such as Pseudomonas aeruginosa than
do untreated control worms. Miyata et al. (2008) suggest that this is a result
of wild type worms prioritising reproduction over immunity (even in the
presence of a lethal pathogen) and that embryonic development decreases
immunity in adult worms. The energy required for the expression of an-
timicrobials used in defence may instead be redirected for use in embryonic
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development. When no energy is required for the development of embryos,
i.e., when worms are grown on FUdR, energy can be allocated to immunity
and therefore worms are able to survive longer. It may also be the case that
FUdR prevents the proliferation of the pathogen.
The use of FUdR in the culturing of C. elegans is relatively common,
and the downstream effects of DNA synthesis inhibition are assumed to
be negligible or, at least, have not been properly examined, despite the
fact that signals from the reproductive system are believed to affect the
lifespan of worms (Hsin & Kenyon, 1999; Lin et al., 2001). The importance
of not simply dismissing the possible effects of FUdR has recently been
highlighted: the tub-1 mutation is involved with fat storage modulation and
has previously been shown to be long–lived (Mukhopadhyay et al., 2005).
However, Aitlhadj & Stu¨rzenbaum (2010) have demonstrated that lifespan
extension in tub-1 worms is seen only when worms are grown in the presence
of FUdR, and that the lifespan–extending properties of the mutation are lost
when worms are grown on standard NGM plates in the absence of FUdR.
This suggests that there may be an interaction between some mutations and
the inhibition of DNA synthesis, and draws attention to the need for careful
controls to avoid misinterpretation when analysing worms cultured in the
presence of FUdR.
The closely related 5-fluorouracil, an anticancer drug, causes defects in
both development and reproduction in C. elegans, as well as resulting in
a smaller body size when worms are hatched onto media containing the
chemical (Kumar et al., 2010). High concentrations cause worms to arrest
at larval stage. Using as low a concentration of FUdR for effective inhibition
of DNA synthesis as possible should help minimise any unwanted effects
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(Gruber et al., 2009). The timing of transfer of worms to FUdR–containing
media is extremely important; transferring worms before growth has ceased
can cause abnormalities in body size and morphology (Mitchell et al., 1979;
Gandhi et al., 1980). In addition to this, in adults, FUdR has been shown
to result in slight changes in the rate of pharyngeal pumping and appears to
increase SOD levels (Mitchell et al., 1979; Gandhi et al., 1980; Vanfleteren
& Vreese, 1995; Gruber et al., 2009).
Nonetheless, FUdR is extremely useful in metabolomic analysis of syn-
chronous ageing worms where large populations are required for adequate
biomass. In addition to this, as FUdR effectively stops reproduction, it
may be a good choice as a manipulator for examining life history trade–offs
involving reproduction – the possible trade–off between reproduction and
longevity, for example. Comparing the metabolic profile of worms grown in
the presence of FUdR with those of worms grown without FUdR should help
to establish how great an effect the chemical has on the metabolism of C. el-
egans, and reveal potential interactions with mutations. This should make
it possible to adequately control for any effects FUdR may have on a given
experiment. Here, I have used proton NMR spectroscopy to examine these
effects by comparing wild type worms with long–lived mutant daf-2(m41)
grown on both standard NGM agar and on agar containing FUdR.
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Figure 4.1: Kaplan–Meier survival analysis for all four treatments: wild type N2 worms
grown on standard NGM agar for the entire experiment; wild type worms transferred to
plates containing FUdR at adulthood; daf-2(m41) mutant worms grown on standard
NGM agar for the entire experiment; daf-2 worms transferred to plates containing FUdR
at adulthood. A: survival curves; B: mean and median age at death for all treatments;
C: Chi–square test statistics. These results suggest that FUdR does not significantly
effect the lifespan of either strain and, irrespective of whether worms have been grown
in the presence of FUdR, there is a significant difference in the lifespan of the two
strains.
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FUdR does not significantly affect the lifespan of wild type
or daf-2(m41) worms
Longevity assays (as described in Chapter 2) were carried out for all four
treatments (wild type N2 worms grown on standard NGM agar; wild type
worms grown on NGM agar with the addition of FUdR; daf-2(m41) mutant
worms grown on standard NGM agar; daf-2 worms grown on NGM agar with
the addition of FUdR) at 20℃. Synchronous populations of wild type worms
and daf-2(m41) worms were grown at 20℃ on standard NGM agar seeded
with E. coli OP50. When both strains had reached young adulthood (defined
here as the point at which eggs were observed but no hatched progeny were
seen, approximately 72 hours post–bleaching), worms were transferred to
new agar plates. For each strain, half of the worms were transferred to
control plates (standard NGM agar) and half to agar plates containing 100
mgl-1 FUdR, both seeded with E. coli OP50. As FUdR prevents all DNA
synthesis, E. coli is not able to proliferate on agar containing FUdR. For
this reason, an overnight E. coli culture was concentrated by a factor of
50 before aliquots were spread on agar containing FUdR, as described by
Mitchell et al. (1979). These seeded plates were then incubated overnight at
37℃ and this resulted in a lawn of E. coli. E. coli culture for the control,
NGM–only plates was prepared in the standard way, as described in chapter
two. This was intended to ensure that the two types of plate contained
comparable amounts of E. coli. All worms, regardless of whether they were
grown on agar containing FUdR, were transferred to new plates every day
during the period in which worms on standard NGM continued to lay eggs.
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After this period, worms were transferred to new plates approximately every
three days.
Figure 4.1 shows the results of a Kaplan–Meier survival analysis on the
data. A, B and C show the resulting survival curves, mean and median age
at death for each treatment and chi–square test results respectively. FUdR
did not significantly affect the lifespan of either strain (p = 0.19 for wild type
worms transferred to FUdR plates at adulthood compared with wild type
worms transferred to control plates, and p = 0.11 for daf-2(m41)) worms
transferred to FUdR plates at adulthood compared with daf-2(m41)) worms
transferred to control plates) and irrespective of whether worms were grown
in the presence of FUdR, there was a significant difference between the
lifespan of the two strains (p = 0.01 on NGM and p <0.001 on FUdR).
FUdR has a greater effect on the C. elegans metabolome
than does genotype
Despite no significant differences in longevity for each strain if transferred
to FUdR–containing plates at adulthood, FUdR may still have an effect
on the metabolome. To investigate this, a large number of synchronised
worms were grown under the conditions described above. After transferring
worms to either plates containing 100 mgL-1 FUdR or control plates, worms
were incubated at 20℃ for 24 hours. After this time, all worms were washed
from plates using M9 buffer and filtered though nylon mesh to remove eggs
and progeny that were present on those plates that did not contain FUdR.
After washing with M9 buffer to remove any E. coli from the worms, the
samples were snap–frozen with liquid nitrogen, and stored at -80℃ before
extraction with 80% methanol and analysis by NMR spectroscopy. Samples
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were randomised for harvesting, sample preparation, and analysis by NMR
spectroscopy in order to eliminate batch effects. Individual metabolites were
identified and quantified for each sample, and the resulting data normalised.
The mean relative concentrations of each metabolite identified are given in
Figure 4.2.
All data were mean–centred and log transformed before principal compo-
nent analysis (PCA). In the two–component model, PC1 and PC2 explain
41% and 11.2% of the variance respectively (R2 (cumulative) = 0.522, Q2
(cumulative) = 0.331). Principal component analysis of all data (Figure 4.3)
suggests that the presence or absence of FUdR has a greater effect on
the metabolome than does the daf-2(m41) mutation, with clear separation
between worms grown on standard NGM and those grown on NGM con-
taining FUdR along PC1, which explains 41% of the total variance in the
data. Though some separation between daf-2 and wild type worms can
be seen along PC2, this principal component explains only 11.2% of the
variance.
The addition of FUdR is associated with changes in the
levels of specific metabolites in both genotypes
Figure 4.4 shows the loadings associated with each principal component
for the model in Figure 4.3. The metabolome of worms transferred to
FUdR plates at adulthood is associated with increased levels of lysine,
putrescine, GPC, acetate, o-phosphocholine and tyrosine compared with
the metabolome of worms transferred to control plates. In contrast, the
metabolome of worms allowed to reproduce normally is associated with
increased levels of cystathionine, trehalose, glutamate and NAD, and slightly
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Figure 4.3: Principal Component Analysis of mean–centred, log transformed data. In
the two component model, PC1 explains 41% of the total variance and PC2 explains
11.2% (Q2 (cumulative) = 0.331). This analysis suggests that whether worms are
grown on agar containing FUdR has a greater effect on metabolome than does genotype,
with clear separation between treatments along PC1. There is also some separation
between strains along PC2. This can be seen most clearly in B, where each data point
is connected to its respective group mean.
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Figure 4.4: Principal Component Analysis of mean–centred, log transformed data.
Corresponding to the scores shown in Figure 4.3, A and B show the loadings for principal
components 1 and 2 respectively.
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increased levels of isoleucine and valine relative to the metabolome of worms
transferred to FUdR plates.
Daf-2(m41) and wild type worms are metabolically distinct,
regardless of whether they are allowed to reproduce
To determine whether metabolic differences could be seen clearly on either
medium, data were grouped according the presence or absence of FUdR, and
analysed in two groups, giving two separate models (Figure 4.5). Again, the
data were mean–centred and log transformed before PCA. A and B show
worms grown on NGM only (R2X (cumulative) = 0.631, Q2 (cumulative) =
-0.112), C and D show strains grown on FUdR only (R2X (cumulative) =
0.384, Q2 (cumulative) = 0.0215). In B and D, each data point is connected
to its respective group mean. The strains grown on standard NGM (A and
B) are clearly separable along the NGM–only model’s second component,
which accounts for 17.7% of the total variance in the model, while in the
FUdR–only model (C and D), strains are separable along the first component,
which explains 19.6% of the variance in that model.
Where worms have been transferred to FUdR, the greatest source of
variance in metabotype is related to genotype (demonstrated by the fact that
the strains can be separated along the model’s first component). However,
where worms remain on control plates, genotype is not the greatest source of
variation. In this model, the second component separates the strains while
the first component does not. It appears that the two strains are easier to
separate and more distinct from one another when both are transferred to
FUdR at adulthood. Despite this, both models clearly separate the two
strains within the first two components. Daf-2(m41) worms are metabolically
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Figure 4.5: Principal component analysis of mean–centred, log transformed data. A
and B show worms grown on NGM only (R2X (cumulative) = 0.631, Q2 (cumulative)
= -0.112), C and D show strains grown on FUdR only (R2X (cumulative) = 0.384, Q2
(cumulative) = 0.0215). In the NGM only model (a four–component model), PC1, PC2,
PC3 and PC4 explain 20.7%, 17.7%, 14.1% and 10.6% of the variance respectively,
though only the first two components are shown here. In the two–component FUdR
only model, PC1 explains 19.6% of the variance and PC2 explains 18.8% of the variance.
A: NGM only, PC1 contributions; B: NGM only, PC2 contributions; C: FUdR only, PC1
contributions D: FUdR only, PC2 contributions The strains grown on standard NGM are
clearly separable along PC2 in the NGM model, while strains grown on plates containing
FUdR are separable along PC1 in the FUdR model. In B and D, each data point is
connected to its respective group mean.
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distinct from wild type worms whether they are allowed to reproduce normally
or are unable to reproduce due to the effect of FUdR.
Metabolites that are most important in separating wild type
and daf-2(m41) worms vary depending on the presence or
absence of FUdR
For each model whose scores are shown in Figure 4.5, the loadings making
up each principal component are shown in figures 4.6 and 4.7. Figure 4.6A
suggests that when worms are transferred to control plates, relatively high
levels of malate, aspartate, threonine and cystathionine are associated with
the daf-2(m41) metabolome, whereas when worms are transferred to plates
containing FUdR, the daf-2(m41) metabotype is different, with relatively
high levels of o-phosphcholine, glutamine, glutamate and, to a lesser extent,
the branched–chain amino acids, isoleucine, leucine and valine compared
with wild type worms.
The same strain–related changes in individual metabolites
can be seen in worms grown on FUdR plates and those
transferred to control plates
Based on principal component analysis, FUdR seems to have a much
greater affect on metabolite levels than does genotype, but the daf-2(m41)
metabolome is clearly distinct from that of wild type worms regardless of
the presence of FUdR. However, the loadings shown in figures 4.6 and 4.7
suggest that the most important metabolites for distinguishing between
strains change based on whether worms are grown on FUdR–containing
plates or control plates, but it is important to know the effects FUdR has
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Figure 4.6: Data separated by treatment, loadings scatter plots. Scores shown in
Figure 4.5. Principal component analysis of mean–centred, log transformed data. A
shows loadings associated with on NGM–only model (R2X (cumulative) = 0.631, Q2
(cumulative) = -0.112). B shows loadings associated with an FUdR–only model (R2X
(cumulative) = 0.384, Q2 (cumulative) = 0.0215).
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Figure 4.7: Data separated by treatment, loadings column plots. Scores shown in
Figure 4.5. Principal component analysis of mean–centred, log transformed data. A
and B show worms grown on NGM only (R2X (cumulative) = 0.631, Q2 (cumulative)
= -0.112), C and D show strains grown on FUdR only (R2X (cumulative) = 0.384, Q2
(cumulative) = 0.0215).
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Figure 4.9: A: log transformed fold change of daf-2(m41) relative to wild type for
worms transferred to FUdR–containing plates versus the log transformed fold change for
worms transferred to control plates. A Reduced Major Axis (RMA) regression suggests
a positive correlation between the fold change values for the two treatments; B: the
negative of the log transformed p–value of daf-2(m41) for each metabolite (based on a
two–tailed t–test comparing the two strains) for worms transferred to FUdR–containing
plates versus the equivalent negative, log transformed p–value for worms transferred
to control plates. Again, an RMA regression has been applied and suggests a positive
correlation between the p–values for each treatment; C: as B but with the exclusion of
tyrosine (whose low p-value may skew the data), which removes the positive correlation
seen in B.
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on the levels of individual metabolites. I.e., are the differences seen in
individual metabolites between wild type and daf-2(m41) worms the same if
worms are grown in the presence of FUdR as they are if worms are allowed
to reproduce? To investigate this, a two–tailed t–test was carried out for
each treatment, testing the differences between each metabolite in the two
strains. In addition to this, the fold change for daf-2(m41) relative to wild
type for each metabolite was calculated. Figure 4.8 shows the result of
the combination of these two analyses. The 0.1, 0.05 and 0.01 significance
levels are shown in each plot, so that all metabolites found at significantly
different levels (p≤0.1) in the two strains are easily identifiable for both
treatments.
Of all metabolites identified, tyrosine and alanine are the only metabolites
to differ significantly (p≤0.05) between strains in both treatments. However,
if the significance level is reduced to 10%, 2-aminoadipate, threonine and
glutamine can also be said to differ significantly in both treatments. Labels
are shown for all metabolites that are found at significantly different levels
(p≤0.1) in the two strains on either FUdR or control plates. Of the 13
metabolites that are present at significantly different levels (p≤0.1) in the two
strains on NGM, nine have the same direction of change on FUdR plates, even
if this change is not significant. Of the 12 metabolites that vary significantly
between strains on FUdR plates, six show the same direction of change
between strains on control plates, even if the change is not significant.
Figure 4.9 B shows the p–value of daf-2(m41) for each metabolite (based
on the same two–tailed t–test comparing the two strains) for worms trans-
ferred to FUdR–containing plates versus the equivalent p–value for worms
transferred to control plates, with a Reduced Major Axis (RMA) regression.
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The R2 and p–values are shown for each regression. In Figure 4.9 C, tyro-
sine has been excluded as it has high leverage. This removes the positive
correlation seen in B. This suggests that generally, those metabolites with
the most significant changes between strains with one treatment will not
necessarily have the most significant changes given the alternative treat-
ment. However, Figure 4.9 A shows, for each metabolite, the fold change of
daf-2(m41) relative to wild type for worms transferred to FUdR–containing
plates versus the equivalent fold change for worms transferred to control
plates. Again, an RMA regression suggests a positive correlation between
the fold change values for the two treatments. The overall trend seems to be
that for each metabolite, the difference between wild type and daf-2(m41)
worms is the same whether worms are allowed to reproduce or transferred
to plates containing FUdR.
Some metabolites appear to be affected by an interaction
between genotype and FUdR or sterility
A two–way ANOVA, where factor A = genotype and factor B = treatment
(i.e presence or absence of FUdR), was carried out (Table 4.1). Metabolites
with a p–value of ≤0.05 for genotype are found at significantly different levels
in the two strains. Metabolites with a p–value of ≤0.05 for treatment are
found at significantly different levels in worms transferred to control plates
in worms transferred to plates containing FUdR. Those metabolites with
an interaction p–value of ≤0.05 may be affected by an interaction between
genotype and FUdR. For these metabolites, the changes seen between strains
may differ depending on whether worms are grown on standard NGM
agar or on NGM agar containing FUdR. Conversely, metabolites with an
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Metabolite p (genotype) p (treatment) p (interaction)
2-Aminoadipate 0.313 0.167 0.002
Acetate 0.037 <0.001 >0.5
Alanine <0.001 0.005 >0.5
Arginine 0.06 0.002 >0.5
Asparagine >0.5 >0.5 0.149
Aspartate 0.004 <0.001 0.413
Betaine 0.012 <0.001 0.014
Choline 0.288 >0.5 >0.5
Cystathionine 0.032 <0.001 0.063
GPC 0.059 <0.001 0.043
Glucose >0.5 0.004 0.083
Glutamate 0.234 <0.001 0.007
Glutamine 0.111 0.191 <0.001
Glycerol 0.004 0.017 0.038
Glycine >0.5 <0.001 >0.5
Isoleucine >0.5 0.001 >0.5
Lactate >0.5 >0.5 0.048
Leucine >0.5 >0.5 >0.5
Lysine 0.044 <0.001 >0.5
Malate 0.015 >0.5 >0.5
NAD+ >0.5 <0.001 0.015
Nicotinate >0.5 0.109 0.31
O-Phosphocholine 0.155 <0.001 0.098
Phenylalanine 0.372 >0.5 0.227
Proline 0.163 0.134 0.38
Propionate >0.5 0.051 0.473
Putrescine >0.5 <0.001 0.414
Succinate 0.191 0.339 0.134
Threonine 0.009 0.46 >0.5
Trehalose >0.5 <0.001 >0.5
Tryptophan 0.194 0.428 >0.5
Tyrosine <0.001 <0.001 0.016
Valine >0.5 0.005 >0.5
Table 4.1: A two–way ANOVA, where factor A = genotype and factor B = treatment
(i.e presence or absence of FUdR), was carried out. Metabolites with a p–value of ≤0.05
for genotype are found at significantly different levels in the two strains. Metabolites
with a p–value of ≤0.05 for treatment are found at significantly different levels in worms
transferred to control plates in worms transferred to plates containing FUdR. Those
metabolites with an interaction p–value of ≤0.05 may be affected by an interaction
between genotype and FUdR. For these metabolites, the changes seen between strains
may differ depending on whether worms are grown on standard NGM agar or on
NGM agar containing FUdR. Conversely, metabolites with an interaction p–value of
>0.05 should show the same changes between strains, regardless of whether worms are
transferred to control plates or FUdR plates at adulthood.
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Figure 4.10: Box and whisker plots for those metabolites that have a significant
interaction p–value (p≤0.05). Some metabolites – glycerol and tyrosine – with a
significant interaction p–value do not seem to be affected by a genotype / treatment
interaction. I.e. the changes between strains appear to occur in the same direction and
to a similar degree on both control and FUdR–containing plates. However, with the
exception of lactate, it can be seen that most of the metabolites predicted to be affected
by an interaction between genotype and treatment do appear to behave differently
depending on whether worms are transferred to FUdR or control plates.
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interaction p–value of >0.05 should show the same changes between strains,
regardless of whether worms are transferred to control plates or FUdR plates
at adulthood.
Figure 4.10 shows box and whisker plots for those metabolites that have
a significant interaction p–value (p≤0.05). Some metabolites – glycerol
and tyrosine – with a significant interaction p–value do not seem to be
affected by a genotype / treatment interaction, i.e. the changes between
strains appear to occur in the same direction and to a similar degree on
both control and FUdR–containing plates. From these plots, however, it
can be seen that most of the metabolites predicted to be affected by an
interaction between genotype and treatment do behave differently depending
on whether worms are transferred to FUdR or control plates. Glutamate,
glutamine and 2-aminoadipate are all found at lower levels in daf-2(m41)
worms than wild type on control plates, but at higher levels in the mutant
worms than wild type if they have been transferred to FUdR–containing
plates. Lactate and NAD follow the opposite pattern, with higher levels
in mutant worms than in wild type on control plates but lower levels in
daf-2(m41) worms on FUdR plates. In some cases, rather than altering
the direction of any difference between strains, FUdR appears to simply
introduce or magnify a change. There is very little difference in GPC levels
between strains on control media, but on FUdR–containing media, mutants
have increased levels of the metabolite. A similar effect is seen in betaine
levels, with little genotype–related difference on control plates but a decrease
with the daf-2(m41) mutation.
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Despite a low interaction test statistic, succinate seems to be
affected by an interaction between genotype and FUdR
Of the metabolites that are predicted not to be affected by a genotype /
treatment interaction, only succinate appears to behave differently depending
on whether or not worms are allowed to reproduce (Figure 4.2). With similar
levels in the two strains when transferred to control plates, succinate levels
seem to decrease in mutant worms relative to wild type in worms that have
been transferred to FUdR–containing plates (Figure 4.11). However, the
two–way ANOVA statistics shown in Figure 4.11C suggest that neither
genotype or treatment have a significant effect on succinate levels (p = 0.191
and p = 0134 respectively).
99
4 5-fluoro-2-deoxyuridine
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
Re
la
tiv
e 
co
nc
en
tra
tio
n
N2 NGM
daf-2 NGM
N2 FUdR
daf-2 FUdR
Dependent Variable
Succinate
Source
A
B
AB
Error
Total
Sum of Squares
0.000800966
0.000421966
0.00106155
0.0152782
Factor A
Strain
Fixed Levels
df
1
1
1
34
37
Two-Way Analysis of Variance (Unweighted Means Analysis)
Mean Square
0.000800966
0.000421966
0.00106155
0.000449359
Factor B
Treatment
Fixed Levels
F
1.78246
0.939038
2.36236
p
0.191
0.339
0.134
Partial 2
0.0192
<= 0
0.0329
0.02
0.03
0.04
0.05
0.06
0.07
M
ea
n 
co
nc
en
tra
tio
n
Strain
NGM
FUdR
N2 daf-2
0.02
0.03
0.04
0.05
0.06
0.07
Treatment
N2
daf-2
NGM FUdR
M
ea
n 
co
nc
en
tra
tio
n
Succinate
A
B
C
Figure 4.11: Despite a low interaction test statistic, succinate appears to be affected
by an interaction between genotype and treatment. With similar levels in the two strains
when transferred to control plates, levels seem to decrease in mutant worms relative to
wild type in worms that have been transferred to FUdR–containing plates. A: Box and
whisker plot showing relative concentration in all four groups, B: interaction plots, C:
Two–way ANOVA statistics imply that neither genotype or treatment have a significant
effect on succinate levels.
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4.3 Discussion
If the reason for the use of 5-fluoro-2-deoxyuridine is purely to help generate
large, synchronised populations of older worms, or to simplify longevity
assays, then ideally the effect of the treatment should be negligible. At
the very least, if comparing mutants, any effect of the treatment should
be significantly less than that of genotype. This is not the case here,
where the use of FUdR has a greater effect on the metabolic profile of
C. elegans than does the daf-2(m41) mutation. This is not surprising,
however, given that FUdR effectively removes the ability of the worms to
reproduce, and the worms sampled were of reproductive age. The second
most favourable situation then, would be that despite any effect being larger
than desired, it may be easily factored out, with no interaction between the
treatment and genotype. Again, this is not the case here, as for a number
of metabolites, there is a clear interaction between FUdR and genotype.
This novel experiment suggests that for this reason, FUdR is not ideal for
use as a tool to simplify the maintenance of synchronised populations when
investigating differences between certain strains, despite widespread use of
the chemical for this purpose. It also demonstrates that in the study of
ageing mutants, longevity assays are insufficient to show that FUdR does
not have a significant effect on a given strain, i.e. while it might not change
one phenotype, it is possible that it affects others.
The inhibition of reproduction with FUdR results in some changes in
metabolome that are seen across strains (Figure 4.4). When reproduction
is inhibited, levels of putrescine increase. Putrescine is not only a product
of the breakdown of amino acids, but is also important in DNA synthesis
(Lee & Maclean, 2011). Inhibiting DNA synthesis would be expected to
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affect levels of this metabolite. The addition of FUdR also increases levels
of phosphocholine. Phosphocholine may be associated with a reduction in
cell turnover, given that it is present in cell membrane bilayers (Swire et al.,
2009).
Worms that are unable to reproduce have decreased trehalose levels. High
levels of trehalose have been linked with increased longevity, but changes in
the levels of trehalose do not appear to be DAF-16 dependent, as described in
Chapter 3. Trehalose appears to be important for egg hatching in nematodes
(Behm, 1997), and therefore may be expected to be affected by the inhibition
of egg production. NAD is also found in lower levels in worms cultured on
FUdR than on those allowed to reproduce. Depletion of NAD is associated
with delays in gonad development and defects in egg laying behaviour in
C. elegans (Vrablik et al., 2009).
The inhibition of reproduction affects which metabolites are most impor-
tant for distinguishing between wild type and daf-2(m41) worms (Figure 4.6).
This clearly demonstrates the importance of taking into account the effects
of FUdR when interpreting results. While in some cases, FUdR may magnify
or introduce changes in metabolite levels between strains (for example, in
GPC, succinate and betaine), in others, an interaction between FUdR and
genotype may have more of an impact, with levels of metabolites changing
in opposite directions between strains depending on whether worms are able
to reproduce. In the mutant, glutamate, glutamine, 2-aminoadipate, lactate
and NAD all change in opposite directions relative to wild type depending
on the presence or absence of FUdR. This interaction should be taken into
account if these metabolites are to be linked with longevity.
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The removal of reproduction will clearly affect the metabolic profile of
worms in a significant way. However, one factor in addition to this that
may have contributed to the substantial differences seen between the two
treatments is the way in which the E. coli food source was prepared for each
type of agar plate. As previously stated, the fact that FUdR prevents all
DNA synthesis means that E. coli is not able to proliferate on agar containing
FUdR. For this reason, an overnight E. coli culture was concentrated by a
factor of 50 before spreading on agar containing FUdR, the method described
by Mitchell et al. (1979). These plates were then incubated overnight at
37℃ and this resulted in a lawn of E. coli. In contrast, E. coli culture
for the control, NGM–only plates was prepared in the standard way, with
overnight bacterial culture spread onto plates (without concentration) and
incubated overnight at 37℃. This meant that the two types of plate contained
comparable amounts of E. coli. One way to eliminate this difference would
be to use a concentrated culture of UV–killed bacteria for both types of
plate, so that neither type of plate contained proliferating E. coli. However,
Mitchell et al. (1979) reported that the response of C. elegans to FUdR was
virtually identical on monoxenic and axenic media, implying that FUdR
does not need to be ingested by the worm to take effect, and any metabolism
of the FUdR by E. coli is unlikely to affect the way that the chemical works.
Differences in the preparation of E. coli for the two types of agar seems
unlikely to have a great effect on the metabolome of the worm, if all worms
are given a sufficient amount of the food source to prevent any dietary
restriction effects, and in both cases the bacteria are metabolically active.
It has been shown previously that worms have a nutritional need for live,
metabolically active microbes as a food source and that worms show dietary
restriction–like effects – increased lifespan and decreased fecundity – when
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grown on UV–killed bacteria (Lenaerts et al., 2008). For this reason, the
use of UV–killed bacteria for all plates may still be far from ideal.
The problem of how to properly separate older worms from their progeny
leads to another possible source of difference between the two treatments.
Worms not transferred to FUdR plates require filtering immediately before
harvesting to remove young worms from the sample. While worms transferred
to FUdR plates do not need to be filtered, all worms were subjected to
the same treatment to control for any possible effect the filtering process
may have on the metabolic profile of the worms. However, filtering may not
completely remove all young worms from the sample, and therefore those
samples where young worms are present, i.e., for those worms transferred to
control plates, more variance in metabolic profile may be expected due to the
variation in metabolic profile with age (as described in Chapter 5). However,
the small size and number of young worms in each sample relative to the total
biomass should have a very small overall effect. In addition to the problem
of young worms in samples, however, is the increased chance of bacterial or
fungal contamination on control plates compared with FUdR plates. This
is due to the fact that any bacterial or fungal contaminants are unable to
propagate in the presence of FUdR. While great care is taken to avoid this
type of contamination on any plate, the transfer of worms at adulthood using
M9 buffer increases the chance of contamination. Again, this may increase
the variation in metabolite levels in worms transferred to control plates
compared with worms transferred to FUdR plates. However, no evidence of
contamination was seen in this experiment. Together, these factors might
help explain the fact that while, in a FUdR–only PCA model, genotype is
the greatest source of variation, in a control plate–only model, strains are
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separated only by the second principal component, so that something other
than genotype is responsible for the most variance (Figure 4.5).
It is clear that using 5-fluoro-2-deoxyuridine simply for the maintenance
of synchronous populations of worms may cause problems, however it is
useful as a tool to investigate the effects of the suppression of reproduction.
While FUdR does not significantly affect the lifespan of either of the two
strains studied here, it is clear that the chemical has a considerable impact
on the C. elegans metabolome. In this case, FUdR has more of an impact on
metabolic profile than does the genotype of the worm. As FUdR suppresses
reproduction, this may not seem surprising. Some reduction in fecundity of
the daf-2(m41) strain compared with wild type worms has been reported
(Gems et al., 1998), and so it might be expected that the removal of one of
the probable sources of variation between the strains (with the addition of
FUdR) may close the gap between the metabotypes of the strains. Based
on principal component analysis (Figure 4.3), it might seem that this is the
case, as the difference between the strain means seems slightly smaller for
worms transferred to FUdR plates than the equivalent distance for control
worms. However, a Euclidian distance of 5.4 between strains on control plates
compared with 7.1 between strains transferred to FUdR plates (calculated
by hierarchical clustering of group medians using standardised variables)
implies that there is a greater difference between strains on FUdR plates
than on control plates. It would be interesting to repeat this experiment
using different daf-2 alleles with fecundity affected to either a greater or
lesser degree, as well as with other ageing mutants with or without altered
fecundity. In addition to this, other methods used to produce sterile worms
– such as fer– mutations – should be investigated for possible interactions
with other mutations. This may help make informed decisions about which
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method would be the most appropriate in a given study. One example
of a case where a possible interaction between mutation and FUdR was
discovered as part of a larger experiment is found in Vanfleteren & Vreese
(1995). Here, it was noted that the presence of FUdR increased the levels
of superoxide dismutase significantly in another daf-2 allele, daf-2(e1370),
whereas this was not the case with the use of a temperature sensitive fer–
mutation. In this case, use of the chemical was discontinued due to this
effect. Given the possible links between life history traits such as longevity or
ageing and reproduction, it may be the case that FUdR, or the suppression
of reproduction, does not interact with all types of mutation – associated
with longevity or otherwise – in the same way. The age at which worms are
sampled may also be important in how great the interaction effect might
be. The effect in much older worms, past reproductive age, may be greatly
reduced.
Conclusion
This experiment was designed to test the effect of 5-fluoro-2-deoxyuridine on
phenotypes other than the previously tested fecundity, ageing or longevity,
by investigating the impact it has on the metabolic profile of C. elegans. It
also demonstrates potential interactions with a commonly used mutation
affecting longevity. The results presented here suggest that the chemical
should be used with care, and that its effects are not necessarily easy to
control for, or factor out completely.
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5 Metabolomic analysis of the
C. elegans life cycle
5.1 Introduction
The life cycle of wild type C. elegans has been well characterised (Byerly et al.,
1976) and consists of an embryonic stage, four larval stages (L1–L4) and an
adult stage. Each stage ends with a cuticle molt followed by the formation
of a new cuticle. Depending on culture temperature, the development of
C. elegans from egg to adult takes 3–5 days. Table 5.1 shows the growth
parameters of wild type C. elegans at 16, 20, and 25℃ (Hirsh & Vanderslice,
1976), with most rapid growth and maximum fecundity at 20℃ (Epstein &
Shakes, 1995). This process is described in more detail in Chapter 1. At
adulthood, the hermaphrodite begins to lay eggs, with egg laying continuing
until around 6 days post–hatching. Wild type hermaphrodite worms have a
lifespan of around three weeks and show signs of ageing including muscle
deterioration and slowing of movement.
There have been several studies investigating the changes in gene expres-
sion that occur during C. elegans larval development (Reinke et al., 2000;
Thoemke et al., 2005; Hill et al., 2000; Jiang et al., 2001; Kirienko & Fay,
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Molts (h post hatch)
Temperature (℃) L1–L2 L2–L3 L3–L4 L4–adult First eggs laid
(h post hatch)
16 24 39 54.5 74.5 94–97
20 15 24 34 46 59–60
25 11.5 18.5 26 35.5 45–46
Table 5.1: C. elegans growth parameters
2007). Capra et al. (2008) compared the developmental expression profiles
of two C. elegans isolates – Bristol N2 and and Hawaii CB4856. Microarrays
were used to obtain profiles for six stages of development (egg, L1, L2, L3,
L4 and young adult) for each strain. The authors found that the expression
of most transcripts vary with stage rather than with strain and that the
greatest variation between strains occurs at the L4 stage, consistent with the
idea that selection relaxes during later developmental stages (Cutter & Ward,
2005). Of the 13,474 genes whose expression was measured, 2211 genes were
expressed at different levels in the two stains at least one of the stages. Some
gene sets were expressed mostly during the egg stage in both strains; some
genes were mostly expressed in either N2 or CB4856, and one gene set was
turned both on and off roughly one stage earlier in CB4856 than in N2. One
of the gene sets that showed these patterns is linked with innate immunity
and the authors suggest that the different expression patterns seen in the
two strains may reflect the different pathogens found in the environments of
the two strains. The low expression of these genes in both strains at the egg
stage may reflect the fact that the egg shell prevents exposure to pathogens
and that most pathogens are ingested and therefore do not affect worms
before they are able to feed.
The effects on metabolism with age (without the direct measurement of
metabolites) in C. elegans have been reviewed by Braeckman et al. (2000).
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Increasing age is associated with a decline in enzyme activity, which seems
to be a result of an increase in altered and damaged proteins due to reduced
protein turnover. In addition to this, the respiration rates of the long–lived
dauer–constitutive mutant age-1 and wild type worms are the same in young
adulthood, and begin to decline similarly with age. However, at 8.5 days,
the decline in respiratory activity in mutant worms slows, and they retain a
significantly higher rate of respiration, suggesting that mutant worms are
biologically younger than predicted by chronological age (Vanfleteren &
Vreese, 1996).
The changes in metabolic profile with age have already been investigated
in organisms other than C. elegans. Wang et al. (2007) looked at the effects
of ageing and dietary restriction (DR) on the metabolome of Labradors
throughout their lifetime using the urinary metabolic profiles of both control–
fed and diet–restricted dogs. Age related changes have also been studied
in rats (Williams et al., 2005), where 1H NMR and HPLC–TOF MS were
used to look at endogenous metabolites excreted in urine. Longitudinal
studies of ageing in C. elegans have already been carried out using gene
expression data. Lund et al. (2002) looked at infertile worms from three
to 19 days old and found that the expression of very few genes – making
up less than 1% of the genome – change with age. Those that do change
include those encoding heat shock proteins (decreased expression with age)
and those encoding some transposases (increased expression with age). An
increase in transposases may be responsible for the destabilisation of the
genome in older worms. It has also been found that gene network integrity
declines with age (Vinuela et al., 2010). Many of the same age related gene
expression changes in C. elegans can be observed across species, and the
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transcriptional profiles of ageing in C. elegans and Drosophila have been
compared (Mccarroll et al., 2004).
By looking at individual worms, age related changes in gene expression
can be studied without the use of fertility mutants or chemicals like FUdR –
single worms can be easily transferred to new plates regularly for separation
from their progeny. Microarrays using individual worms have been used to
link age–related behaviours to gene expression (Golden et al., 2008) and also
to compare wild type worms with a long–lived mutant (Golden & Melov,
2004). In this comparison, four adult ages were sampled in both wild type
and daf-2(e1370) between days four and 19. Again, changes in the expression
of genes associated with heat shock proteins are seen, and this is the case in
both strains. Other genes were found that differentiate the ageing process
in wild type from ageing in daf-2(e1370), including genes associated with
proteins with anti–fungal properties and those that encode for electron
transport chain components of mitochondria (more highly expressed in old
wild type worms compared with old daf-2 worms). In addition to this, genes
that code for proteasome components increase in expression in wild type
worms with age but not in daf-2 worms. The authors suggest that this
may be because wild type worms require a greater capability for protein
degradation as they age due to an increase in the occurrence of malformed
proteins, and that this process is accelerated in wild type relative to daf-2
worms. It may be the case that these gene expression changes occur in
daf-2(e1370) worms after the final, 19–day sampling time point.
Like daf-2(e1370), daf-2(m41 ) is a long–lived, temperature–sensitive,
dauer–constitutive IIS mutant. It has a smaller adult body size than other
daf-2 mutants (McCulloch & Gems, 2003) and a mean brood size that
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is around 11% lower than wild type mean brood size. Here, I have used
proton NMR spectroscopy to study the changes that occur in this mutant
during normal development and ageing in comparison to the changes that
occur in wild type worms, sampling at all larval stages, young adults of just
reproductive age, and six other adult time points.
5.2 Results
Synchronised populations of both strains were grown at 20℃ on NGM plates
until early adulthood. Each strain was sampled at each larval stage (L1, L2,
L3 and L4) and at young adulthood, which was defined as the point at which
some eggs were seen on plates but no second generation worms had hatched.
At this point, worms were transferred to plates containing fluorodeoxyuridine
(FUdR). As described in Chapter 4, this results in sterile worms and so
ensured that the ageing populations continued to be synchronous without
daily transfer to new plates, so that a single generation of ageing worms
was maintained. After transfer to FUdR plates, worms were sampled at
days 6, 8, 10, 13, 16 and 20 days post–hatching for each strain. Due to the
slight difference in development time between the wild type and mutant,
the times, post–hatching, at which the sampling of developmental stages
occurred varied slightly between strains.
As wild type worms reached adulthood before daf-2(m41) worms, the two
strains were transferred to FUdR plates at different time points to ensure
that both strains were fully grown before the inhibition of DNA synthesis.
The sampling and transfer times for both strains are given in Figure 5.1.
Due to the large scale of the experiment and the biomass required for each
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13 hours 22 hours 33 hours 61 hours45 hours
80 hours60 hours48 hours30 hours21 hours
Time
L2 L4 Young adultsL3L1
L1 L2 L3 L4 Young adults
0 hours
 Worms hatch from eggs
(synchronised population)
0 hours
Wild type
daf-2(m41) 
 Worms hatch from eggs
(synchronised population)
Wild type
daf-2(m41) 
0 hours
0 hours
Time
80 hours
61 hours 6 days 8 days 10 days 13 days 16 days 20 days
Transfer worms 
to FUdR plates
Transfer worms 
to FUdR plates
 Worms hatch from 
 eggs (synchronised 
        population)
 
Worms hatch from 
 eggs (synchronised 
        population)
A
B
6 days 8 days 10 days 13 days 16 days 20 days
Figure 5.1: Sampling time points for wild type and daf-2(m41) mutant worms during
development (A) and adulthood (B), reflecting the differences in development rates
between strains.
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sample, it was not possible to carry out the entire experiment using the
same population of worms. Therefore, the experiment was carried out in
two stages. The first stage included larvae and young adults (all grown on
standard NGM plates) and the second stage consisted of all other adult time
points (all grown on NGM plates containing FUdR).
At each sampling time point, worms were washed from plates with M9
buffer and allowed to settle at the bottom of a 15 ml centrifuge tube for
three minutes. The M9 supernatant was then removed and the worm pellet
transferred to small centrifuge tube and snap–frozen with liquid nitrogen.
Remaining worms were washed from plates and transferred to fresh, E.
coli–seeded plates on day ten. Extra E. coli OP50 was washed in M9 buffer
and then pipetted onto plates (after sampling) at days 6, 8, 13 and 16 to
ensure the worms were not starved at any time. Samples were stored at -80℃
before extraction with 80% methanol and analysis by NMR spectroscopy.
Six biological replicates were analysed per time point, per strain. Samples
were randomised for harvesting, sample preparation, and analysis by NMR
spectroscopy in order to eliminate batch effects. Individual metabolites were
identified and quantified for each sample as described in Chapter 2 and the
resulting data normalised using median fold change normalisation.
The C. elegans metabolome changes considerably with
age
Figure 5.2 shows the relative concentrations for all metabolites identified for
both strains at all time points. The normalised data have been scaled to unit
variance and a hierarchical cluster analysis was used to cluster metabolites
along the x axis. The Z–value refers to the number of standard deviations
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Figure 5.2: Heat map showing the relative concentrations for all metabolites identified
for both strains at all time points. The normalised data have been scaled to unit variance
and a hierarchical cluster analysis was used to cluster metabolites along the x axis. The
Z–value refers to the number of standard deviations from the mean value. During the
life cycle of the worm, many metabolites show changes in relative concentration, with
a clear overall change in metabolic profile occurring at the larval / adult boundary in
both strains.
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from the mean value. During the life cycle of the worm, many metabo-
lites show changes in relative concentration, with a clear overall change in
metabolic profile occurring at the larval / adult boundary in both strains.
The branched–chain amino acids (BCAAs), isoleucine, leucine and valine
are seen to decrease in relative concentration at adulthood regardless of
genotype, although the rate of decrease in the daf-2(m41) worms appears
to be slower and than that seen in wild type worms. In wild type worms, a
clear shift is seen in these metabolites at adulthood. Conversely, phospho-
choline, glycerophosphocholine and glycine are all seen to increase in relative
concentration at adulthood.
Wild type and daf-2(m41) mutant worms follow different
developmental trajectories
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Figure 5.3: For larval stages and young adults, principal component analysis (PCA)
was carried out on unit variance scaled data. In the two component model, the first
component explains 32% of the total variance in the data and the second component
explains 11.2% of the variance (Q2 (cumulative) = 0.256). A shows the mean score on
each principal component for each time point for a given strain, along with trajectory
lines for each strain. Error bars represent the standard error of the mean. B shows all
data points for both strains.
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For larval stages and young adults, principal component analysis (PCA)
was carried out on unit variance scaled data. In the two component model,
the first component explains 32% of the total variance in the data and the
second component explains 11.2% of the variance (Q2 (cumulative) = 0.256).
The scores on both components are shown in Figure 5.3. Here, B shows all
data points for both strains, but A shows the mean score on each principal
component for each time point for a given strain, along with trajectory lines
for each strain. At the L1 stage, wild type and daf-2 mutants have similar
scores in PC1 and PC2, but as development progresses, the trajectories of
the two strains separate. At L2, the mutant worms have a considerably
higher score on PC1 than wild type worms, although the strains have similar
PC2 scores. Both strains move to a lower score on PC1 between L2 and
L3 but then move in different directions along PC1 between L3 and L4.
The greatest difference between strains is seen in the progression from L4
to young adulthood. A relatively small shift along PC1 with time is seen
in mutant worms, with little change in PC2 score. In wild type worms
however, only a small change in PC1 score is seen but there is a large shift
in a negative direction along PC2. This results in the young adult wild type
and mutant worms having different scores on both principal components.
Figure 5.4 shows the corresponding loadings for this analysis.
Wild type and daf-2(m41) worms are metabolically distinct
for the whole development period
In order to look at larval stages and young adults for both strains in more
depth, all data were mean–centred and log transformed before an Orthogonal
Partial Least Squares (OPLS) regression (where the y variable was time (in
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Figure 5.4: Loadings corresponding to the PCA in Figure 5.3.
hours) post–hatching) was carried out, with the results shown in Figure 5.5
(R2X (cumulative) = 0.512, R2Y (cumulative) = 0.825, Q2 (cumulative)
= 0.656). Figure 5.5 A shows scores and Figures 5.5 B and C show the
corresponding loadings. By looking at the time–correlated component, it
can be seen that if we consider both strains simultaneously, development
from L1 to young adult is associated with an increase in trehalose, serine,
glutamate and alanine and a decrease in the branched–chain amino acids as
well as phenylalanine, malate and choline. Given that the y–variable was
set as time, this analysis was supervised with respect to age, but not with
respect to strain. Despite this, a clear separation between strains is seen
along the first orthogonal component at all stages, indicating that the two
strains behave differently over the developmental period. By looking at the
loadings associated with the first orthogonal component it can be seen that
high levels of trehalose, tyrosine and o–phosphoserine are linked with daf-2
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Figure 5.5: For larvae and Young Adults (YA), an OPLS analysis (y = hours post
hatching)was carried out (R2X (cumulative) = 0.512, R2Y (cumulative) = 0.825, Q2
(cumulative) = 0.656). Data were mean centred and log transformed prior to analysis.
A shows the resulting scores, B shows loadings for the correlated component and C
shows loadings for the first orthogonal component. This analysis was supervised with
respect to age but not with respect to strain. Despite this, a clear separation between
strains is seen along the first orthogonal component at all stages, indicating that the
two strains behave differently over the developmental period.
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worms compared with high levels of lactate, succinate and o–phosphocholine
in wild type worms.
Different metabolite changes are associated with
development in wild type worms compared with long–lived
daf-2(m41) mutants
The same mean–centred and log transformed data were then analysed using
an Orthogonal Partial Least Squares Discriminant Analysis (OPLS–DA),
with the Y variable distinguishing between the two strains. The results are
shown in Figure 5.6, with scores shown in A and loadings for the strain–
correlated component and first orthogonal component in B and C respectively
(R2X (cumulative) = 0.504, R2Y (cumulative) = 0.893, Q2 (cumulative)
= 0.802). The different developmental stages are less distinct from each
other and more closely clustered together in daf-2 mutants than in wild type
worms. By looking at the strain–correlated component loadings (Figure 5.6
B), it can be seen that daf-2(m41) larvae have relatively high levels of
the BCAAs, tyrosine, lysine and phosphoserine, whereas wild type larvae
have relatively high levels of succinate, glutamate, betaine, putrescine and
o-phosphocholine. In contrast to the OPLS regression in Figure 5.5, here
the analysis is supervised with respect to genotype but unsupervised with
respect to age. However, a progression from L1 to young adult can be seen
in both strains in the same direction along the first orthogonal component.
The loadings relating to the first orthogonal component show that if we
consider the two strains together, L1 worms have relatively high levels of
choline, malate, GPC and the BCAAs, whereas by young adulthood, worms
have higher levels of trehalose, betaine and serine.
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Figure 5.6: Mean centred, log transformed larvae and young adult (YA) data were
analysed using OPLS–DA, where data were classed according to genotype (i.e. daf-
2(m41) or wild type). (R2X (cumulative) = 0.504, R2Y (cumulative) = 0.893, Q2
(cumulative) = 0.802). A shows the resulting scores, B shows loadings for the correlated
component and C shows loadings for the first orthogonal component. Here the analysis
is supervised with respect to genotype but unsupervised with respect to age. However,
a progression from L1 to young adult can be seen in both strains in the same direction
along the first orthogonal component.
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5.2 Results
Daf-2(m41) mutants and wild type worms follow different
ageing trajectories
Principal component analysis (PCA) was carried out using adult worm data
only (beginning at 6 days post hatching for each strain and ending at 20 days
post hatching). This resulted in a four component model, however only the
first three components are shown in Figure 5.7. The first, second and third
components explain 28%, 14.3% and 10.4% of the of the variance respectively
(R2X (cumulative) = 0.597, Q2 (cumulative) = 0.339). Here, A, C and E
show the mean score on each principal component for each time point for a
given strain, along with trajectory lines for each strain. B, D and F show all
data points for both strains. If we consider only the first two components
(Figures 5.7 A and B), some similarities in the ageing trajectories between
strains can be seen. Both strains mostly progress with a similar trajectory
with respect to direction between time points in both components. However,
in most cases, the magnitude of the change of position between time points
is much greater in wild type worms than in daf-2(m41) worms. The overall
range in both components is also smaller in daf-2 worms than in wild type
worms. If we consider a third component (Figures C–F), differences between
the trajectories of the two strains as they age become much more apparent.
The corresponding loadings plots are given in Figure 5.8.
Young adults, able to reproduce, may be included in an
analysis of ageing in sterile adults
As the experiment was carried out in two stages, and no samples at the
same time point were included in both experiment sets, it is possible that it
would not be appropriate to analyse time points from the first part of the
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Figure 5.7: For adults (days 6 to 20 post hatching), principal component analysis
was carried out on unit variance scaled data. This resulted in a four component model,
however only the first three components are shown here. The first, second and third
components explain 28%, 14.3% and 10.4% of the of the variance respectively (R2X
(cumulative) = 0.597, Q2 (cumulative) = 0.339.) A, C and E show the mean score
on each component for each time point for a given strain, along with trajectory lines
linking each strain. Error bars represent the standard error of the mean. B, D and F
correspond to A, C and E respectively, and show all data points.
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Figure 5.9: To determine whether the ‘young adult’ stage from the first part of the
experiment may be grouped with subsequent adult time points in further analysis, a
PLS regression was carried out using all adult time points. The data were mean–centred
and log transformed prior to this analysis and the results are shown in Figure 5.9. A
shows both strains in a regression using wild type as a training set, where Y = time
and B shows the results of two cross–validation methods in addition to this.
experiment together with time points from the second part of the experiment.
The ‘young adults’ sampled in the first part of the experiment were grown
on standard NGM agar and therefore were able to reproduce, whereas all
other adult worms had been transferred to FUdR–containing plates at young
adulthood to prevent the production of progeny. To determine whether the
‘young adult’ stage from the first part of the experiment may be grouped
with subsequent adult time points in further analysis, a PLS regression was
carried out using all adult time points. The data were mean–centred and log
transformed prior to this analysis and the results are shown in Figure 5.9. A
shows both strains in a regression using wild type as a training set, where Y
= time and B shows the results of two cross–validation methods in addition
to this. The plots demonstrate that young adults (here, the first time point)
fall close to the line y=x, suggesting that it is appropriate to include this
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time point in further analysis of the ageing adult data. It can also be seen
that daf-2(m41) mutants fall further from the line y=x than either of the
data points obtained in cross validation analysis (Figure 5.9 B).
Daf-2(m41) and wild type worms are metabolically distinct
throughout adulthood
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Figure 5.10: Adult data (including Young Adults (YA)) were mean centred and log
transformed before an OPLS analysis (where y = age in hours post hatching) was
carried out. (R2X (cumulative) = 0.496, R2Y (cumulative) = 0.904, Q2 (cumulative)
= 0.871). A shows the resulting scores, B and C show the loadings for the correlated
component and first orthogonal component respectively. this analysis was supervised
with respect to age, but not with respect to strain. However, as with the larval data, a
clear separation between strains can be seen in the first orthogonal component.
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All adult time points (including ‘young adults’) were included in an OPLS
analysis similar to that carried out for larval data. Here, the y variable
was equal to time (in hours) post–hatching and the results of this analysis
on mean–centred, log transformed data are shown in Figure 5.10 (R2X
(cumulative) = 0.496, R2Y (cumulative) = 0.904, Q2 (cumulative) = 0.871 ).
A shows scores and B shows the corresponding loadings. The age–correlated
component loadings show that the metabolomes of younger worms are defined
by relatively high levels of succinate, cystathionine, glutamate, glutamine
and the BCAAs isoleucine and valine, while older worms show increased
levels of o-phosphoserine, o-phosphocholine, GPC, citrate and glycine. Given
that in this model the regression was performed against time, this analysis
was supervised with respect to age, but not with respect to strain. However,
as with the larval data, a clear separation between strains can be seen in the
first orthogonal component. Although the wild type and mutant worms can
be separated in this way as they age, this effect does seem to lessen as time
progresses, with the strains becoming less distinct with age. By considering
the first orthogonal component loadings (Figure 5.10 C), it can be seen that
the wild type adult metabotype features relatively high concentrations of
glutamate, choline and o-phosphocholine while the daf-2(m41) metabotype
includes high levels of tyrosine, glycerol, o-phosphoserine and malate.
Some metabolite changes that occur during the ageing
process are independent of genotype
The adult data were then analysed using OPLS–DA, with the Y variable
grouping the data according to genotype. The results are shown in Fig-
ure 5.11, with scores shown in A and the corresponding loadings shown
126
5.2 Results
-1.0 -0.5 0.0 0.5
Correlated component
-1.0
-0.5
0.0
0.5
Fi
rs
t o
rth
og
on
al
 c
om
po
ne
nt
day10
day10
day10 day10day10
day13
day13day13
day13
day13
day16
day16day16
day16
day20
day20day20 day20
day6 day6
day6
day6
day6
day8
day8day8
day8
day8
YA YA
YA
day10
day10
day10
day10
day10
day13day13 day13
day13
day16day16
day16
day16
day16
day20
day20
day20
day20
day20
day6
day6 day6
day6 day6
day8
day8
day8day8
YA
YA
YA
N2
daf-2(m41)
Gl
yc
er
ol
Tr
eh
al
os
e
Va
lin
e
Le
uc
in
e
Ty
ro
si
ne
As
pa
ra
gi
ne
Is
ol
eu
ci
ne
NA
D+
Gl
ut
am
in
e
O-
Ph
os
ph
os
er
in
e
M
al
at
e
Pr
ol
in
e
Al
an
in
e
Ph
en
yl
al
an
in
e
Th
re
on
in
e
La
ct
at
e
Su
cc
in
at
e
Cy
st
at
hi
on
in
e
Hi
st
id
in
e
As
pa
rta
te
M
et
hi
on
in
e
Ac
et
at
e
Ly
si
ne
Se
rin
e
Gl
yc
in
e
Ar
gi
ni
ne
Gl
ut
am
at
e
GP
C
Be
ta
in
e
Ch
ol
in
e
Ci
tra
te
O-
Ph
os
ph
oc
ho
lin
e
Pu
tre
sc
in
e
Metabolite
-0.3
-0.2
-0.1
0.0
0.1
0.2
0.3
0.4
Co
rre
la
te
d 
co
m
po
ne
nt
Su
cc
in
at
e
Gl
ut
am
at
e
Ac
et
at
e
Cy
st
at
hi
on
in
e
Ar
gi
ni
ne
Is
ol
eu
ci
ne
Be
ta
in
e
Ly
si
ne
Pu
tre
sc
in
e
Va
lin
e
Hi
st
id
in
e
Ch
ol
in
e
La
ct
at
e
Ph
en
yl
al
an
in
e
M
et
hi
on
in
e
Al
an
in
e
As
pa
rta
te
Le
uc
in
e
As
pa
ra
gi
ne
Gl
ut
am
in
e
Ty
ro
si
ne
NA
D+
Gl
yc
er
ol
Th
re
on
in
e
Pr
ol
in
e
Ci
tra
te
Se
rin
e
M
al
at
e
Gl
yc
in
e
O-
Ph
os
ph
os
er
in
e
O-
Ph
os
ph
oc
ho
lin
e
Tr
eh
al
os
e
GP
C
Metabolite
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0.0
0.1
0.2
0.3
0.4
Fi
rs
t o
rth
og
on
al
 c
om
po
ne
nt
A
CB
Figure 5.11: Adult data (including Young Adults (YA)) were mean centred and
log transformed before an OPLS–DA analysis was carried out, with classes based on
genotype (i.e. daf-2(m41) and wild type). (R2X (cumulative) = 0.485, R2Y (cumulative)
= 0.737, Q2 (cumulative) = 0.668). A shows the resulting scores, B shows the loadings
for the correlated component an C shows the loadings for the first orthogonal component.
Here the analysis is supervised with respect to strain but unsupervised with respect
to age, but a progression from young adult to 20–day–old adults can be seen in both
strains from lower to higher score in the first orthogonal component.
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in B and C ( R2X (cumulative) = 0.485, R2Y (cumulative) = 0.737, Q2
(cumulative) = 0.668). The strain–correlated component loadings (Fig-
ure 5.11 B) suggest that high levels of the BCAAs, glycerol, trehalose and
tyrosine define an adult daf-2(m41) worm, whereas high levels of putrescine,
o-phosphocholine, citrate, choline and betaine are associated with adult
wild type worms. Here the analysis is supervised with respect to strain but
unsupervised with respect to age, but a progression from young adult to
20–day–old adults can be seen in both strains from lower to higher score in
the first orthogonal component. The first orthogonal component loadings
can be seen in (Figure 5.11 C), and show that if we consider the two strains,
young adults are are associated with relatively high levels of succinate, glu-
tamate, acetate and cystathionine, but as worms age, there is an increase in
relative concentration of o-phosphoserine, o-phosphocholine, trehalose and
GPC.
Based on metabolic profile, daf-2(m41) worms are predicted
to be younger than their chronological age
For each part of the C. elegans life cycle, i.e. development and ageing,
an OPLS regression was carried out, with time as a Y variable. In both
models, data were scaled to unit variance and the Y variable was equivalent
to time (in hours or days for larvae and adults respectively). Figure 5.12
shows the results of this analysis for larvae (A) and adults (B), with models
generated based on wild type worms only. For larvae, (R2X (cumulative) =
0.506, R2Y (cumulative) = 0.945, Q2 (cumulative) = 0.898 B. For adults,
R2X (cumulative) = 0.322, R2Y (cumulative) = 0.938, Q2 (cumulative) =
0.916. The line y=x is shown in each plot. ‘Chronological age’ refers to
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Figure 5.12: An OPLS regression was carried out for both larvae (R2X (cumulative)
= 0.506, R2Y (cumulative) = 0.945, Q2 (cumulative) = 0.898) and adult data (days
6 to 20 post–hatching) (R2X (cumulative) = 0.322, R2Y (cumulative) = 0.938, Q2
(cumulative) = 0.916) shown in A and B respectively. Data were scaled to unit variance
before the analysis and the line y=x is shown in each plot. Models were generated
based on wild type worms only. ‘Chronological age’ refers to the time at which worms
were sampled and ‘predicted age’ refers to the age predicted by the model based on
metabolome. based on these metabotypes, both adult and larvae daf-2(m41) worms
are predicted to be younger than their chronological (sampling) age.
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Figure 5.13: Loadings corresponding to Figure 5.12. A and B show which metabolites
determine wild type age in larvae and adults respectively.
129
5 Life cycle analysis
the time at which worms were sampled and ‘predicted age’ refers to the
age predicted by the model based on metabolome. Figure 5.13 shows the
corresponding loadings; A and B show which metabolites determine wild
type age in larvae and adults respectively. In larval and young adult wild
type worms, development is associated with a decrease in the concentration
of BCAAs, choline, phenylalanine and malate, and an increase in betaine,
glutamate, arginine and glycine. For wild type adult worms, the ageing
process involves a decrease in glutamate, glutamine, cystathionine, histidine
and trehalose and an increase in GPC, phosphoserine, putrescine, glycine
and citrate. Figure 5.12 shows that based on these metabotypes, daf-2(m41)
worms are predicted to be younger than their chronological (sampling) age at
each time point during development. During adulthood, differences between
the two strains increase with age, with daf-2 worms predicted to be just
younger than their chronological age from day 13, with clear differences
between predicted and chronological age from day 16.
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Figure 5.14: An OPLS regression against time was carried out for both larval–stage
(R2X (cumulative) = 0.28, R2Y (cumulative) = 0.732, Q2 (cumulative) = 0.616) and
adult (R2X (cumulative) = 0.333, R2Y (cumulative) = 0.81, Q2 (cumulative) = 0.769)
daf-2 worms. A and B show the correlation between score and age for development
and ageing respectively.
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Figure 5.15: Loadings corresponding to the model in Figure 5.14. A and B show
metabolites ordered in terms of importance for determining daf-2(m41) development
and ageing respectively. To help identify which metabolites are of different importance,
or behave differently, in determining age in the two strains, C and D show metabolites
ordered according to importance in determining wild type development and ageing (i.e.
as Figure 5.13).
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Figure 5.16: The pattern of change in trehalose and tyrosine with age in adult worms.
Mean values are shown, with error bars representing the standard error. In ageing
daf-2(m41) worms, trehalose concentration is strongly positively correlated with an
increase in age and tyrosine is negatively correlated with age. In wild type worms, the
reverse is true; trehalose levels decrease, and tyrosine levels increase with age.
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For comparison, an OPLS regression against time was carried out for
both larval–stage (R2X (cumulative) = 0.28, R2Y (cumulative) = 0.732, Q2
(cumulative) = 0.616) and adult (R2X (cumulative) = 0.333, R2Y (cumu-
lative) = 0.81, Q2 (cumulative) = 0.769) daf-2 worms (Figure 5.14). The
loadings for the correlated component are shown in Figure 5.15. A and B
show metabolites ordered in terms of importance for determining daf-2(m41)
development and ageing respectively. For daf-2 worms, development is
associated with a decrease in the BCAAs, phenylalanine, acetate, lysine
and methionine and an increase in glutamate, alanine, putrescine, trehalose,
serine and cystathionine. Ageing in this mutant is associated with a decrease
in histidine, succinate, the BCAAs and cystathionine and an increase in
GPC, glycine, trehalose, o-phosphocholine and citrate with time. Many of
these changes are similar to the changes seen in development and ageing in
wild type worms as detailed above.
To help identify which metabolites are of different importance, or behave
differently, in determining age in the two strains, figures 5.15 C and D
show metabolites ordered according to importance in determining wild type
development and ageing respectively (i.e. as Figure 5.13). It can be seen
that choline, tyrosine and o-phosphoserine, which are associated with early
development in wild type worms, are not strongly associated with this stage
in daf-2 worms. Acetate and NAD, however, are much more important
when defining early development in daf-2 worms than in wild type worms.
Phosphocholine, glycine, arginine and betaine become increasingly abundant
with development in wild type worms, but this is not the case in daf-2
worms. In ageing mutant worms (Figure 5.15 D), trehalose concentration is
strongly positively correlated with an increase in age and tyrosine and lysine
levels are negatively correlated with ageing. In wild type worms, the reverse
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is true; higher than average levels of trehalose are associated with young
adulthood and increasing relative concentration of both lysine and tyrosine
is linked with increasing age. Figure 5.16 shows the patterns of change of
trehalose and tyrosine with age. As in development, in ageing choline follows
a different pattern of relative concentration in the two strains, being more
important in defining young wild type worms than daf-2(m41) worms.
5.3 Discussion
It is clear to see that the C. elegans metabolome changes considerably
with age, regardless of genotype (Figure 5.2), and this is unsurprising given
the many processes that take place over the course over the life cycle of
a worm. The most distinct change is seen at the development / ageing
boundary and again, this was to be expected – the processes involved in the
development of a worm from larva to adult will be very different from those
that occur during the ageing process. More interestingly, the two strains
remain distinct at all time points through both development and ageing
(Figures 5.5 and 5.10). It can be seen that if the metabolic profile as a whole
is considered, long–lived daf-2(m41) mutants follow different trajectories
from wild type worms in terms of both development and ageing (Figures 5.3
and 5.7). To further investigate the main differences between the strains, it
is necessary to consider changes in the relative concentrations of individual
metabolites.
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Development
In the transition from L1 to young adult, the changes in the majority of the
amino acids identified and quantified here are consistent with the balloon
hypothesis (Swire et al., 2009), and this is the case for both strains. In this
model, the need for the production of cell membrane components lessens
relative to the production of cytoplasmic components over the course of
development. This is due to the fact that in C. elegans, cells expand in volume
without dividing during development so that body size increases without
the increase in cell number (Flemming et al., 2000). The balloon hypothesis
suggests that amino acid usage is not driven by age but by geometry, and
that during development, the production of cytoplasmic proteins increases
and the production of membrane proteins decreases. Amino acid pools
are affected by the requirement for either mainly hydrophobic amino acids
or hydrophilic amino acids to make up membrane or cytoplasmic proteins
respectively.
During development, the changes seen in the levels of certain metabolites
are different in wild type and daf-2(m41) worms. Phosphocholine, glycine,
arginine and betaine all increase and choline and tyrosine decrease consider-
ably in relative concentration with time in developing wild type worms, but
all show much smaller changes in daf-2(m41) worms (Figure 5.15). Tyrosine
is a precursor to melanin, which has been found to have a protective function
in C. elegans as a Reactive Oxygen Species (ROS) scavenger (Calvo et al.,
2008). Decreasing levels of tyrosine in wild type worms as they approach
adulthood may mean they have a reduced capacity to form melanin and are
therefore at increased risk of oxidative damage. The decrease in choline and
the increase in phosphocholine, glycine and betaine (all choline metabolites)
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with age in wild type worms does not occur to such a great extent in mutant
worms, pointing to differences in the changes in lipid metabolism and lipid
turnover between the two strains as they age.
Ageing
Some metabolites show similar patterns of change during the ageing process
in the two strains. Levels of the branched–chain amino acids (BCAAs)
decrease as worms age in both wild type and daf-2 worms. However, it can
be seen that BCAA levels are higher in daf-2 adults than in wild type adults
(Figure 5.11) and this is consistent with previous results (Fuchs et al., 2010).
For C. elegans, as for other animals, these amino acids are essential (Payne
& Loomis, 2006), so differences in their pool sizes result only from changes
in their catabolism, in protein turnover or uptake. Fujita & Volpi (2006)
suggest that these amino acids may directly stimulate protein synthesis, as
well as being precursors for this synthesis. A decreasing pool of amino acids
with age may be linked with a decrease in protein synthesis. Supplementation
with the BCAAs have been found to increase chronological lifespan in yeast
(Alvers et al., 2009) and longevity in mice (D’antona et al., 2010), as well as
resulting in improvement in some age–related diseases in both rats (Pansarasa
et al., 2008) and humans (Solerte et al., 2008b). In mice it was found that
an increase in lifespan with BCAA supplementation was accompanied by
increased mitochondrial biogenesis and SIRT1 expression and that ROS
defence system genes were upregulated, reducing oxidative damage. The
reduced change in BCAAs with age observed in daf-2 worms compared with
wild type worms may help explain their increased longevity.
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Other metabolites that show decreasing relative concentration with age in
both strains are histidine, glutamine, and glutamate. Histidine is another
essential amino acid and a component of carnosine; histidine and carnosine
may contribute to antioxidant protection in rats (Chan et al., 1994). As
histidine seems to be one of the most important metabolites in determining
age in both strains, the link with antioxidant protection may point to a
reason for the decrease in this amino acid with age. Decreasing levels of
glutamine and glutamate with age in both strains is consistent with findings
in both rat (Banay-Schwartz et al., 1989; Benedetti et al., 1990) and human
(Kaiser et al., 2005) brains. Phosphocholine and GPC increase with age
in both strains (though this is more a feature of wild type ageing than
of daf-2(m41) ageing), pointing to altered lipid metabolism with age. An
increase in age is also correlated with an increase in putrescine, which is a
product of the breakdown of amino acids, which corresponds to the decrease
seen in many of the amino acids here.
Trehalose levels change in opposite directions with age in the two strains.
In wild type worms, levels decreases with age, whereas in daf-2(m41) worms
levels increase with age. The disaccharide is an important carbohydrate
storage molecule, thought to confer stress resistance in many invertebrates
(Behm, 1997; Pellerone et al., 2003). As described in Chapter 3, trehalose has
long thought to be a ‘longevity assurance sugar’, with genes involved in its
synthesis found to be upregulated in IIS mutants (Lamitina & Strange, 2005;
McElwee et al., 2006), and this is consistent with the differences between
strains seen here.
Honda et al. (2010) found that trehalose lengthens C. elegans lifespan.
It was found that very shortly after beginning treatment in 20–day adult
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worms, trehalose suppressed the age–related decline in survivorship, and that
while treatment of 10–day adult age worms for a ten day period extended
mean lifespan, treatment from the first day of adulthood for ten days did
not increase longevity. The authors suggest that trehalose protects against
the increased stress that occurs with age, but is unable to repair damage
to proteins that has already occurred during the ageing process. This can
be directly linked with the pattern of change in trehalose levels with age
here. In wild type worms, trehalose levels start to decrease from around
10 days post–hatching – for comparison, this is the equivalent of around
7–day adults – with the rate of decline increasing at day 13 post–hatch (day
10 adults). Trehalose treatment at day 10 of adulthood would therefore
replenish trehalose stores just as they seem to begin to naturally deplete.
Feeding worms between days 1 and 10 of adulthood (days 4 to 13 post–
hatching) has no effect on lifespan, possibly because trehalose levels are
still naturally high in worms during this period (Figure 5.16). The natural
increase in trehalose levels with age in daf-2(m41) mutants studied here
might explain why the authors saw no effect of trehalose treatment on the
lifespan of another daf-2 mutant.
Tyrosine also behaves differently with age depending on genotype, but in
contrast to trehalose, relative concentration increases with age in wild type
worms and decreases with age in daf-2 worms. As detailed above, tyrosine is
a precursor to melanin, an ROS scavenger (Calvo et al., 2008). An decrease
in tyrosine pools in daf-2 worms may represent increased melanin production
with age, contributing to reduced oxidative damage and an increased lifespan.
Tyrosine is a non–essential amino acid for C. elegans, and can be synthesised
from phenylalanine, which follows the same pattern of change as tyrosine
in both strains. This is consistent with the fact that many genes encoding
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components of the catabolic pathways of phenylalanine and tyrosine are
regulated in daf-2 worms (Dong et al., 2007; Fisher et al., 2008).
Some metabolites appear to be important in the ageing process in one
strain but not in the other. For example, there is very little change in
relative concentration of lysine in wild type worms, but ageing in daf-2(m41)
worms is strongly associated with a decrease in this essential amino acid.
Conversely, asparagine levels show only small changes in mutant worms but
decrease with age in wild type worms.
Based on metabotype, daf-2(m41) worms are predicted to
be younger than their chronological age
In both development and ageing, long–lived daf-2 worms have a metabotype
that is younger than expected based on chronological age (Figure 5.12). Dur-
ing development, worms are predicted to be younger than their chronological
(sampling) age at each time point. During adulthood, differences between the
two strains increase with age, with daf-2 worms predicted to be just younger
than their chronological age from day 13, with clear differences between
predicted and chronological age from day 16. This is, in part, consistent
with the findings of Vanfleteren & Vreese (1996), in which a long–lived dauer
constitutive mutant is found to have a slowed rate of decline of respiratory
activity with age, so that mutant worms appear biologically younger than
their chronological age. Based on metabolic profile, it seems that throughout
development, mutant worms are younger than predicted at all ages, while in
adults, the difference between biological age and chronological age in mutant
worms seems to increase with age. In addition to this, the respiration rates
of the long–lived dauer–constitutive mutant age-1 and wild type worms are
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the same in young adulthood, and begin to decline similarly with age. How-
ever, at 8.5 days, the decline in respiratory activity in mutant worms slows,
and they retain a significantly higher rate of respiration, suggesting that
mutant worms are biologically younger than predicted by chronological age
(Vanfleteren & Vreese, 1996). The differences in the metabolic changes that
occur with the ageing process in the two strains highlight the importance of
choosing carefully the time points used in wild type / mutant comparisons.
This is especially important if only a single time point is to be chosen.
Experiment limitations and further work
Although a significant shift in metabolism is to be expected at the larval /
adult boundary, with the end of development and the onset of ageing, it is
possible that some changes may be an artefact of the transfer to different
media (i.e. plates containing FUdR). However, as can be seen from the
regression analysis in Figure 5.9, for both strains, the last time point on
standard NGM plates – the young adults – seems to fit well with the later
adult time points, which were sampled from plates containing FUdR. In
addition to this, worms were transferred to fresh (FUdR) plates on day 10.
No obvious change is seen at this point in either Figure 5.9 or Figure 5.2.
As shown in Chapter 4, the use of FUdR when investigating ageing, and
comparing mutants, is far from ideal as any effects of reproduction on ageing
are not taken into account. In a preliminary experiment, adult worms were
regularly filtered using nylon mesh to remove progeny in an attempt to
maintain a synchronised population throughout adulthood. However, this
method was unable to remove all young worms and so by day 20, populations
were no longer synchronised and contained worms at many stages. The old
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adult worms could not be separated from younger adult worms. In addition
to this, the filtering method increases the likelihood of bacterial and fungal
contamination on plates, and this problem increased with sampling age due
to repeated filtration and extra time for contaminants to proliferate on plates.
The combination of decreasingly synchronised populations and increasing
contamination would have been likely to result in false trends with time. It
was decided that this would have caused a greater problems in interpreting
results than the use of FUdR which, with using previous results (Chapter 4)
can to a certain extent be controlled for. When grown on FUdR plates,
adult populations remain synchronous and the problem of contamination is
effectively eliminated.
The timing of the transfer of worms to FUdR plates is extremely important.
Worms should not be transferred to FUdR plates before they reach adulthood
so that they are able to develop normally, but should be transferred before
any hatched progeny appear on plates. The two strains have slightly different
development times and for this reason, spent different periods of time in
the presence of FUdR (a difference of 19 hours) as during adulthood, both
strains were sampled based on number of days post–hatching (Figure 5.1).
This problem is difficult to overcome, but one solution may have been to
sample worms based on time post–maturity. However, the effect of being
exposed to FUdR for different periods is likely to decrease with time, as the
time difference becomes much smaller relative to sampling age. In addition
to this, lifespan statistics are generally quoted in terms of absolute age
(post–hatching), rather than age–post maturity so that comparisons based
on chronological age based on time of hatching seem sensible.
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This experiment investigated only normal development and did not include
dauer larvae. The wild type dauer larvae metabolome has already been well
characterised by NMR (Fuchs et al., 2010), however it would be interesting
to compare the metabolic profile of wild type dauer larvae with that of daf-
2(m41) dauers. In addition to this, wild type worms were sampled very close
to their maximum lifespan of around 21 days in this laboratory (Chapters 3
and 4), however daf-2(m41) worms have a maximum lifespan of around 28
days (again, under the conditions of this laboratory). Continuing to sample
daf-2 worms after the 20–day point may highlight further similarities and
differences in the ageing process between the two strains.
Conclusion
As a first characterisation of the C. elegans metabolome throughout both
development and ageing, these results provide an insight in the metabolic
changes that occur with time. The comparison of these changes in wild
type worms with the changes in a mutant known to show differences in both
of these processes help to determine the point at which point long–lived
mutants begin to acquire their long–lived phenotype. This has allowed the
prediction of results of research published subsequently. For example, the
importance of the timing of trehalose treatment in extending C. elegans
lifespan (Honda et al., 2010) could have been predicted using relative changes
in trehalose levels that occur naturally in worms as they age.
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6 Metabolomic analysis of
mutation accumulation in
C. elegans
6.1 Introduction
New mutations are the source of genetic variation. Mutation Accumulation
(MA) experiments have played a key role in determining what is known
about how spontaneous mutations contribute towards genetic variation, in
addition to their effect on fitness (reviewed by Halligan & Keightley, 2009).
The purpose of a MA experiment is to reduce natural selection to as great a
degree as possible, and this is achieved by splitting an ancestral line into a
number of MA, lines which are then allowed to accumulate mutations for a
given number of generations, by reproducing in an environment lacking in
selection pressure. Mutations that arise will then either be lost or fixed in
subsequent generations and each line may accumulate different combinations
of mutations. The majority of mutations appear to be either neutral or
harmful, given that they perturb highly adapted systems (Lynch et al., 1999;
Drake et al., 1998). In addition to the fact that mutations that result in a
visible phenotype are usually deleterious, the high degree of conservation of
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protein-coding sequences compared with non-coding DNA regions, suggests
that most changes in amino acids are deleterious, as individuals with harmful
mutations either die or fail to reproduce (Keightley & Eyre-Walker, 1999).
For this reason, there is likely to be not only an increase in genetic variation
between lines, but also a decrease in mean fitness in the MA lines compared
with the ancestral line.
Many MA experiments are concerned with the rate at which new mutations
accumulate in the genome (Denver et al., 2005a; Garcia et al., 2010; Lynch
et al., 1995; Phillips et al., 2009; Baer et al., 2005, 2007), and the effect of
those mutations on fitness traits, including reproduction (Estes et al., 2004;
Baer et al., 2006), body size (Azevedo et al., 2002; Salomon et al., 2009)
and behavioural responses (Ajie et al., 2005). They have also been used to
investigate the recovery from deleterious mutations (Denver et al., 2010).
Denver et al. (2005b) investigated the effect of mutation accumulation on
the C. elegans transcriptome and found that the evolution of gene expression
occurs at a greater rate than the evolution of genes themselves, probably in
part due to the fact that a single mutation in one regulatory locus is likely to
affect many other genes. It was also found that not all biological processes
or functions at the molecular level are equally mutable. For example, the
transcriptional stability of genes that are involved in signal transduction
pathways are under relatively high levels of stabilising selection. In contrast,
the transcription of genes involved in carbohydrate, amino acid and lipid
metabolism pathways are under less stringent stabilising selection than
many other sets of genes. Baer & Denver (2010) used microarrays to look
at transcripts from four C. elegans MA lines, along with their common
ancestor, and found that the transcriptome of MA lines varies less with
environmental change than that of their common ancestor. This suggests
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that deleterious mutations reduce gene expression sensitivity to small random
environmental changes.
C. elegans is an ideal organism for mutation accumulation experiments.
As the great majority of a population of worms will be hermaphrodites, its
mode of reproduction by self–fertilisation results in what can essentially be
considered clonal propagation. A minimum population size of one worm
per generation allows for the elimination of natural selection, and only
lethal mutations or mutations that result in sterile worms are able to escape
propagation. In order to generate C. elegans mutation accumulation lines,
one larva from the progeny of a single worm is selected at random and
allowed to produce its own progeny. One of these second–generation larvae
will be selected at random and allowed to reproduce, and this process
will be repeated until the desired generation number has been reached
(Figure 6.1).
It has already been shown that changes in the C. elegans metabolome are
clearly related to traditional fitness components such as longevity (Chapters 3
and 5) and reproduction (Chapter 4). Using metabolomics to study mutation
accumulation lines allows us to estimate the impact of spontaneous variation
on many traits (metabolites) simultaneously. Here, Gas–Chromatography
Mass–Spectrometry (GC–MS) has been used to analyse the metabolic pro-
files of over forty mutation accumulation lines and their common ancestor,
assumed to be free of mutations. The aim of this experiment is to identify
the metabolic basis of mutational fitness variation. It may be the case that
the changes in some metabolites correlate with fitness, or that each line
has a unique change in metabolome compared with its ancestor. It is also
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Synchronised 
ancestral 
population
Repeat for x 
generations
One larva picked at random and allowed to 
produce progeny 
(one generation) 
Repeat to give
 n MA lines
 
 Common ancestor 
preserved as control
 
     n 
MA lines
Figure 6.1: Generation of C. elegans Mutation Accumulation lines. One larva from
the synchronised progeny of a single worm is selected at random and allowed to produce
its own progeny. One of these second–generation larvae will then be selected at random
and allowed to reproduce. This process is repeated so that mutations are allowed to
accumulate over x generations. After x generations, each of n lines is expected to have
accumulated different combinations of mutations. As the majority of mutations are
deleterious, this results in an overall decrease in fitness relative to a control line (the
preserved common ancestor of the n MA lines.)
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possible that changes may be seen in the metabolic profile as a result of
mutation accumulation that have no impact on fitness.
Particular metabolites may be particularly susceptible to mutation. It may
be the case that the propensity of a metabolite to change with mutation ac-
cumulation is in some way linked with its connectedness within the metabolic
network, so that, for example, highly connected or critical metabolites are
less likely to change with mutation than less–critical metabolites. Selvarasu
et al. (2010) calculated values for the ‘centrality’ of metabolites in a genome–
scale model of a mouse metabolic network. These values are freely available
as supplementary data (Selvarasu et al., 2010, Supplementary Material 5),
and will be used here to investigate a link between metabolite centrality and
propensity to change with mutation accumulation. The authors’ analysis gen-
erated two values for the centrality of a given metabolite: ‘degree centrality’
and ‘betweenness centrality’, helping to identify highly linked and bridging
metabolites. Degree centrality is a measure of the number of links incident
upon a given metabolite, while betweenness centrality is a measure of a
node’s centrality in a network as a whole. Betweenness centrality is useful
as a measure of the total load placed on a given metabolite in a network,
rather than just localised connectivity (Selvarasu et al., 2010).
The MA lines profiled here were acquired from the Baer lab (University
of Florida). The creation of the lines (over a total of 200 generations) is de-
scribed in detail in Baer et al. (2005). Lines were then allowed to accumulate
mutations over an additional 50 generations, giving 250–generation MA lines
for metabolomic analysis. The Baer lab measured fitness by counting the
number of hatched eggs produced by each line over a three day period. This
was carried out at 100 generations, 200 generations and 220 generations and
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these data will be used in an attempt to link metabotype with reproductive
fitness.
6.2 Methods
Worms received from the Baer lab were washed from plates on arrival, using
M9 buffer and frozen (as described in Chapter 2) before storage at -80℃
until use. To grow lines for sampling, worms were thawed on unseeded NGM
plates and incubated overnight at 20℃. Plates were then ‘chunked’, with
a small (approx. 1cm2) uncontaminated area containing a large number
of worms onto NGM plates seeded with E. coli OP50. For each MA line,
five of these plates were made, giving five biological replicates per line. For
ancestral worms, ten replicates were made. All lines were then allowed
to reproduce until plates had reached a point suitable for synchronisation
by treatment with hypochlorite. Following synchronisation, worms were
incubated at 20℃ until young adulthood, defined here as the point at which
some eggs were seen on plates but no second generation worms had hatched.
At this point, worms were washed from plates with M9 buffer and allowed to
settle naturally at the bottom of a 15 ml centrifuge tube for three minutes.
The M9 supernatant was then removed and the worm pellet transferred to
small centrifuge tube and snap–frozen with liquid nitrogen. Samples were
stored at -80℃ before extraction with 80% methanol and analysis by GCMS.
Samples were randomised for harvesting, sample preparation, and analysis
by GC–MS in order to eliminate batch effects. Individual metabolites were
identified and quantified for each sample (as described in Chapter 2) and
the resulting data normalised using median fold change normalisation.
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6.3 Results
Overview
Empty samples and obvious outliers were removed, along with the metabolites
with the lowest retention times, which could not be reliably quantified. Mean
values were calculated for each metabolite for each line. Figure 6.2 shows
the log transformed fold change of mean concentration relative to mean
ancestral level for each metabolite. A two–way Hierarchical Cluster Analysis
(based on Euclidian distance) was used to cluster metabolites along both
axes. The dendrogram showing the clustering of the lines is shown, with
clear separation of the lines into two groups.
Principal Component Analysis
To further investigate the grouping observed in Figure 6.2, a principal
component analysis was carried out. The filtered dataset was scaled to unit
variance and log transformed before PCA. This resulted in a six component
model (R2X (cumulative) = 0.725, Q2 (cumulative) = 0.413), with the first
four components explaining 28.7%, 18.4%, 8.9% and 6.8% of the variance
respectively. Figures 6.3, 6.4 and 6.5 show the results of this analysis (first
four components only). It can be seen that ancestral samples fall at the
edge of the data, tending towards a high score on PC1, PC2 and PC3 and a
score close to zero on PC4. It can also be seen that the data are separable
into two populations on PC2, with all ancestral samples contained in one of
these groups.
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Figure 6.3: Principal component analysis of unit variance scaled, log transformed data
(six component model, where R2X (cumulative) = 0.725, Q2 (cumulative) = 0.413).
A shows scores on PC1 vs scores on PC2 and B shows the corresponding loadings.
Principal components 1 and 2 explain 28.7% and 18.4% of the variance respectively.
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Figure 6.4: Principal component analysis of unit variance scaled, log transformed data
(six component model, where R2X (cumulative) = 0.725, Q2 (cumulative) = 0.413).
A shows scores on PC2 vs scores on PC3 and B shows the corresponding loadings.
Principal components 2 and 3 explain 18.4% and 8.9% of the variance respectively.
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Figure 6.5: Principal component analysis of unit variance scaled, log transformed data
(six component model, where R2X (cumulative) = 0.725, Q2 (cumulative) = 0.413).
A shows scores on PC2 vs scores on PC4 and B shows the corresponding loadings.
Principal components 2 and 4 explain 18.4% and 6.8% of the variance respectively.
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The lines can be grouped into two populations
In order to help view the grouping of the data on PC2, error bars were
added to PCA score plots, showing the standard error of the mean for each
MA line for the given components (Figure 6.6 A, B and C). The two groups
can now be seen more clearly and a histogram, showing the distribution
of the scores on PC2 (Figure 6.6 D) confirms the bimodal distribution of
scores on this component. In order to confirm that this grouping related
to variance between but not within MA lines, a box and whisker plot was
constructed (Figure 6.7), with lines ordered according to their median score
on PC2. This demonstrates that the two groups observed on PC2 are related
to individual lines. While some overlap and a slight gradient can be seen,
generally lines either score high on PC2 or low or PC2, enabling the lines to
be grouped into two sets. This grouping is consistent with that seen in an
HCA in Figure 6.2.
Which metabolites separate these two groups?
Figure 6.8 shows the loadings for the second principal component, which
separates the lines into two groups. It can be seen that a low score on PC2
is associated with relatively high levels of adenosine, xanthine, nicotinic acid,
allose and mannose, whereas a low score is associated with relatively high
levels of palmitic acid, aspartate, serine, stearic acid, 6-hydroxyhexanoic
acid, citrate and 2-hydroxyproline.
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Figure 6.6: Principal component analysis scores (unit variance scaled, log transformed
data, a six component model, where R2X (cumulative) = 0.725, Q2 (cumulative) =
0.413). A, B and C show scores for PC1 vs PC2; PC2 vs PC3 and PC2 vs PC4
respectively, with the addition of error bars (showing standard error of the mean score)
for each MA line. Viewing the data in this way allows two groups to be seen clearly
in PC2. D, a histogram which shows two groups of scores in the distribution of PC2,
confirms this.
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Number of metabolites changed
Line (p≤0.1) (p≤0.05) (p≤0.01) (p≤0.001)
503 11 8 1 1
504 23 20 14 12
505 14 11 5 2
507 23 20 15 9
508 21 16 9 6
509 12 12 5 3
511 23 21 15 9
513 11 8 5 3
514 22 19 12 5
516 17 14 10 5
517 9 8 4 2
520 11 11 5 3
522 22 18 12 3
523 16 13 6 5
524 10 8 3 1
525 12 7 3 2
528 16 13 8 5
529 22 18 13 7
530 14 9 4 3
536 18 11 10 5
540 23 22 15 12
542 20 17 14 11
543 29 27 24 18
544 20 16 13 9
546 17 10 4 4
547-B 15 13 12 6
548 13 9 5 3
552 16 13 5 3
555 17 14 14 8
563 20 18 11 9
564 25 23 20 9
567 21 20 10 6
570 24 17 8 5
571 10 8 4 1
573 27 23 21 17
574 6 5 2 1
575 19 14 8 3
577 12 9 5 2
581 25 20 13 10
582 8 5 2 0
592 21 17 10 5
593 13 11 6 3
595 19 17 11 5
598 16 16 12 10
Table 6.1: A set of t–tests were carried out on the median fold change normalised,
log transformed data, comparing the mean level of each metabolite in each MA line
with its mean level in ancestral worms. Summing the number of changed metabolites
allowed the identification of the lines with the greatest number of metabolite level
changes compared with ancestral worms. The analysis was carried out at four different
levels of significance; p≤0.1, p≤0.05, p≤0.01 and p≤ 0.001.
157
6 Mutation accumulation
ad
en
os
in
e
xa
nt
hi
ne
ni
co
tin
ic
 a
ci
d
al
lo
se
m
an
no
se
ly
xo
se
ol
ei
c 
ac
id
rib
os
e
he
pt
ad
ec
an
oi
c 
ac
id
ad
en
in
e
m
et
hi
on
in
e
ty
ro
si
ne
try
pt
op
ha
n
be
nz
oi
n
su
cc
in
at
e
N-
ac
et
yl
-L
-h
is
tid
in
e
ur
ac
il
Ph
en
yl
al
an
in
e
ly
si
ne
m
al
ic
 a
ci
d
as
pa
ra
gi
ne
3-
am
in
oi
so
bu
ty
ric
 a
ci
d 
al
an
in
e
ur
ic
 a
ci
d
gl
yc
in
e
pa
nt
ot
he
ni
c 
ac
id
gl
ut
am
at
e
fu
m
ar
ic
 a
ci
d
tre
ha
lo
se
pu
tre
sc
in
e
po
rp
hi
ne
N-
m
et
hy
l-D
L-
gl
ut
am
ic
 a
ci
d 
py
ro
gl
ut
am
at
e
2-
hy
dr
ox
yp
ro
lin
e
ci
tri
c 
ac
id
6-
hy
dr
ox
yh
ex
an
oi
c 
ac
id
st
ea
ric
 a
ci
d
se
rin
e
as
pa
rta
te
pa
lm
iti
c 
ac
id
Metabolite
-0.4
-0.3
-0.2
-0.1
0.0
0.1
0.2
0.3
Co
nt
rib
ut
io
n 
(P
C2
)
Figure 6.8: Loadings on PC2 corresponding to the principal component analysis in
Figures 6.3, 6.4 and 6.5. PC2 explains 18.4% of the total variance in the data.
Some lines have more metabolite levels changed with
respect to ancestral levels than others
T–tests were carried out on the median fold change normalised, log trans-
formed data, comparing the mean level of each metabolite in each MA line
with its mean level in ancestral worms. Summing the number of changed
metabolites allowed the identification of the lines with the greatest number
of metabolite level changes compared with ancestral worms. The analysis
was carried out at four different levels of significance: p≤0.1, p≤0.05, p≤0.01
and p≤ 0.001 and the results are shown in Table 6.1, and as histograms
in Figure 6.9. At the 95% confidence level, the lines that have the most
metabolite level changes are 543 (27), 564 (23), 573 (23), 540 (22), and 511
(21). The number of metabolites whose levels are significantly different from
ancestral levels is given in brackets for each line. The lines with the fewest
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Figure 6.9: Histograms showing the distribution of the number of metabolites with
levels significantly different from ancestral levels per line for four significance levels;
p≤0.1, p≤0.05, p≤0.01 and p≤ 0.001.
159
6 Mutation accumulation
metabolite level changes are 525 (5), 574 (5) and 582 (7). The number of
metabolites that have significantly changed levels compared with control
levels correlates negatively with the mean score on PC2 for a given line at
all significance levels (Figure 6.10).
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Figure 6.10: The number of metabolites that have significantly changed levels
compared with control levels in a given MA line correlates negatively with the mean
score on PC2. This is the case at all significance levels.
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Number of lines in which metabolite changes
Metabolite (p≤0.1) (p≤0.05) (p≤0.01) (p≤0.001)
serine 4 4 1 0
glycine 3 2 0 0
nicotinic acid 33 32 28 23
succinic acid 44 43 40 32
porphine 13 9 2 0
uracil 11 6 2 1
fumaric acid 18 17 13 8
6-hydroxyhexanoic acid 17 15 7 3
methionine 31 27 18 8
alanine 9 5 1 0
aspartate 37 30 22 14
3-aminoisobutyric acid 4 1 1 0
2-hydroxyproline 33 26 22 17
malic acid 20 15 6 3
pyroglutamic acid 23 23 13 7
glutamate 7 4 1 0
phenylalanine 9 7 4 2
asparagine 16 11 4 0
lyxose 21 18 16 9
ribose 23 21 16 10
N-methyl-DL-glutamic acid 21 16 6 2
putrescine 2 1 1 1
citric acid 10 6 1 1
adenine 14 11 5 0
allose 39 33 20 12
benzoin 7 4 4 2
mannose 37 32 20 10
lysine 6 3 1 0
tyrosine 16 10 3 1
pantothenic acid 32 30 18 13
xanthine 24 21 16 12
palmitic acid 22 12 7 2
uric acid 1 12 7 0 0
N-acetyl-L-histidine 10 6 1 1
heptadecanoic acid 31 31 25 13
tryptophan 6 3 1 0
oleic acid 34 34 23 14
stearic acid 18 13 7 4
adenosine 31 30 26 22
trehalose 15 10 6 4
Table 6.2: Using t–test results comparing the mean level of each metabolite in each
MA line with its mean level in ancestral worms, the number of lines in which the level of
a given metabolite changed significantly compared with ancestral worms was calculated.
This allowed the identification of the metabolites whose levels were most likely to change
with the accumulation of mutations. Again, this was carried out at four different levels
of significance; p≤0.1, p≤0.05, p≤0.01 and p≤ 0.001.
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Figure 6.11: For each metabolite identified and quantified, the fold change relative
to the ancestral line was calculated. The log2 fold change ratios for metabolites with
relative concentration most likely to change with mutation accumulation are shown
here. Of the metabolites with relative concentrations most likely to change with
mutation accumulation, succinate, oleic acid and nicotinic acid all increase relative to
the ancestral line while aspartate, methionine and 2-hydroxyproline all decrease relative
to the ancestral line.
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The levels of some metabolites are more likely to be affected
by mutation accumulation than others
Using the same t–test results, the number of lines in which the level of a
given metabolite changed significantly compared with ancestral worms was
calculated. This allowed the identification of the metabolites whose levels
were most likely to change with the accumulation of mutations. Again,
this was carried out at four different levels of significance; p≤0.1, p≤0.05,
p≤0.01 and p≤0.001. The results are shown in Table 6.2. At the 95%
confidence level, the metabolites with levels that are most likely to change
with mutation accumulation are succinate, oleic acid, allose, nicotinic acid,
mannose, aspartate, 2-hydroxyproline and methionine. The metabolites with
levels that are the least likely to change are lysine, tryptophan and glycine.
Putrescine and 3-aminoisobutyrate both change in just one line. For each
metabolite identified and quantified, the fold change relative to the ancestral
line was calculated. The log2 fold change ratios for metabolites with relative
concentration most likely to change with mutation accumulation are shown
in Figure 6.11. Of the metabolites with relative concentrations most likely
to change with mutation accumulation, succinate, oleic acid and nicotinic
acid all increase relative to the ancestral line while aspartate, methionine
and 2-hydroxyproline all decrease relative to the ancestral line.
Metabolite centrality
In order to test the hypothesis that the propensity of the levels of a given
metabolite to change as a result of mutation accumulation is correlated with
the centrality of that metabolite, metabolite data from a mouse model were
used (Selvarasu et al., 2010). The Spearman’s rank correlation coefficient (ρ)
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Figure 6.12: The Spearman’s rank correlation coefficient (ρ) and corresponding
p–value were calculated to test the relationship between the propensity of a metabolite
to change (the number of lines in which levels of a metabolite are changed relative
to ancestral levels) and the centrality of that metabolite. Values were calculated for
each significance level given in section 6.3. Betweenness centrality was found to be
significantly negatively correlated with propensity to change with mutation (p = 0.048)
using p≤0.1 values for propensity to change. At p≤0.05, p≤0.01 and p≤0.001, p–values
for correlation were 0.055, 0.078 and 0.085 respectively. A Reduced Major Axis (RMA)
regression line is shown for each analysis.
164
6.3 Results
and corresponding p–value were calculated to test the relationship between
the propensity of a metabolite to change (the number of lines in which levels
of a metabolite are changed relative to ancestral levels) and the degree and
betweenness centrality of that metabolite. Values were calculated for each
significance level given in section 6.3. Betweenness centrality was found
to be significantly negatively correlated with propensity to change with
mutation (p = 0.048) using p≤0.1 values for propensity to change. At
p≤0.05, p≤0.01 and p≤0.001, p–values for correlation were 0.055, 0.078
and 0.085 respectively. For significance levels p≤0.1, p≤0.05, p≤0.01 and
p≤0.001, ρ values were -0.370, -0.360, -0.332 and -0.326 respectively.
For each of these significance levels, the correlation between betweenness
centrality and propensity to change is shown in Figure 6.12. A Reduced
Major Axis (RMA) regression line is shown for each analysis.
No significant correlation was found between propensity of a metabolite
to change and degree centrality.
Correlation between metabotype and fitness
The Spearman’s rank correlation coefficient (ρ) and corresponding p–value
were calculated to test the relationship between each metabolite and fitness
(based on total lifetime egg production). Fitness data were provided for the
lines at three time points: after 100, 200 and 220 generations of mutation
accumulation. As this study looked at the lines after 250 generations
of mutation accumulation, this analysis was carried out using the fitness
data for the closest time point of 220 generations. However, this fitness
assay was carried out at 25℃, while populations grown for metabolomic
analysis were incubated at 20℃. To take this temperature difference into
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Figure 6.13: The Spearman’s rank correlation coefficient (ρ) and corresponding
p–value were calculated to test the relationship between each metabolite and fitness
(based on total lifetime egg production). This analysis was carried out on two fitness
datasets: an assay at 20℃ after 200 generations of mutation accumulation and an assay
at 25℃ after 220 generations of mutation accumulation. The relative concentration
of only one metabolite, N-acetyl-L-histidine, was found to correlate with fitness in
either assay (p = 0.000096 and p = 0.00060 for 200 generations and 220 generations
respectively). A linear, Y on X regression and corresponding r value is shown for each
analysis.
166
6.4 Discussion
account, correlation analysis was also performed using fitness data recorded
at 200 generations, as this assay was carried out at 20℃. This analysis was
performed using mean values for total lifetime egg production and mean
relative metabolite concentrations as well as mean scores on the principal
components from the earlier PCA. A Bonferroni correction was applied to a
95% significance level, giving a corrected threshold of p = 0.001. At this level,
the relative concentration of only one metabolite, N-acetyl-L-histidine, was
found to correlate with fitness in either assay (p = 0.000096, ρ = 0.634 and
p = 0.00060, ρ = 0.544 for 200 generations and 220 generations respectively).
Figure 6.13 shows this positive correlation, with r values based on a linear,
Y on X regression. There was no correlation between fitness and the score
on PC2, the principal component separating the lines into two groups.
6.4 Discussion
It is clear that the accumulation of mutations over 250 generations results
in significant changes to the C. elegans metabolic profile. With the change
in fitness that is observed as a result of this mutation accumulation, this is
not surprising. However, rather than all MA lines having metabolomes that
are changed in the same manner, the change in metabolome appears to tend
towards two distinct end points, with the MA lines forming two groups in a
PCA analysis along the second principal component (Figure 6.6). One group,
consisting of ancestral worms and 24 of the 47 MA lines have a high score on
PC2 while the remaining MA lines have lower PC2 scores. The mean score
on PC2 is negatively correlated with the number of metabolites that have
significantly changed over the 250 generations of mutation accumulation
(Figure 6.10), indicating that one group contains lines that have changed
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relatively little over the 250 generations in terms of metabolic profile and the
second group contains lines which have metabolomes that have been more
greatly affected by the accumulation of mutations. The grouping of the lines
is consistent with the HCA in Figure 6.2, where one group can be seen to
have a greater number of high fold change values than the other.
The separation of lines into two distinct groups is a surprising result.
There are two outcomes that would have seemed more likely: firstly, that
each MA line was metabolically distinct from the ancestral line in its own
way. Secondly, that there would be a continuous spectrum of metabolic
change, from ancestral worms to the lines with the most metabolites affected
by mutation. One possible explanation is that the groups separate lines
based on their developmental age. As described, lines were sampled at
young adulthood, defined here as the point at which some eggs were seen
on plates but no second generation worms had hatched. Once all lines had
started laying eggs, all lines were sampled at one time point, so that all lines
sampled were at the same chronological age. However, the slight variation in
development times between lines may have resulted in slight variation in age
in terms of development. It is possible that this may have contributed to
the grouping of the lines, with worms with a delayed onset of reproduction
looking metabolically less like ancestral worms than worms with development
times close to those of ancestral, mutation–free worms. As stated, samples
were randomised for harvesting, sample preparation, and analysis by GC–MS
in order to eliminate as many external factors that may lead to grouping
as possible. It is possible that other measures of fitness, such as body size,
would correlate with score on PC2.
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The groups are associated with two distinct metabotypes. High scores on
PC2 (as seen in ancestral worms) are associated with relatively high levels
of metabolites such as 2-hydroxyproline, serine and aspartate, and low levels
of adensoine, xanthine and nicotinic acid. Low scores on PC2 (lines where
more metabolites are affected by mutation accumulation) are associated
with high levels of adensoine, xanthine and nicotinic acid, which may be
related to changes in nucleotide turnover and degradation, and low levels of
2-hydroxyproline, serine and aspartate. Serine and aspartate are involved
in sphingolipid metabolism, and relatively low levels of these metabolites
in lines that have low scores on PC2 (and a greater number of metabolites
differing from ancestral levels) point to an alteration of lipid metabolism
in this group. It is possible that this is linked with a greater number of
mutations in these lines relative to the ancestral line.
Some metabolites identified are more likely to change with mutation accu-
mulation than others. These include succinate, oleic acid and nicotinic acid,
which all increase relative to the ancestral line, and aspartate, methionine
and 2-hydroxyproline, which decrease relative to the ancestral line. The
relative concentrations of these ‘most likely to change’ metabolites appear to
change in a largely uniform direction, i.e. they either increase or decrease in
the great majority of MA lines. Nicotinic acid, involved with the metabolism
of NAD+ and nicotinamide, has been linked with regulation of reproduction
in C. elegans (Vrablik et al., 2009), with delays in gonad development and
defects in egg laying behaviour associated with depletion of NAD+ and
accumulation of nicotinamide respectively.
Nicotinic acid is found at increased concentrations in those MA lines
that appear to be more affected by mutation accumulation than others,
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and this change may be associated with a decrease in fitness in these lines.
2-hydroxyproline is a posttranslationally modified amino acid, which has
been detected in dauers (Fuchs et al., 2010) and high levels are likely to be
the result of protein degradation. Hydroxyproline is a major component of
collagen and is one of the metabolites that is most likely to change (and
decrease) in MA lines, and may point to changes in collagen production or
degradation in MA lines. The increase in succinate relative to the ancestral
line in all MA lines, suggesting that carbohydrate metabolism may be altered
in a similar way in all lines. Oleic acid is a monounsaturated fatty acid, found
to suppress stress resistance and reduce viability in C. elegans fatty acid
metabolism mutants (Horikawa & Sakamoto, 2009). Oleic acid is increased
in all but two MA lines relative to the ancestral line and this, along with the
suggested involvement of fatty acid metabolism in regulating stress tolerance
mechanisms may be linked with the decreased fitness seen in MA lines.
The levels of other metabolites are apparently more stable. For example,
levels of the amino acids lysine, tryptophan and glycine change with mutation
accumulation in very few lines and the level of putrescine changes in just one
line. Putrescine is a product of the breakdown of amino acids, suggesting
that this process may not be affected by mutation accumulation. It may
be the case that these stable metabolites are critical for the survival of the
worm.
A weak, negative correlation was observed between the propensity of the
levels of a metabolite to change with mutation and its centrality (betweenness
centrality only), or its connectedness, within a metabolic network. However,
the centrality data used here were obtained from a mouse model (Selvarasu
et al., 2010), and it may be the case that centrality values for metabolites in
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a C. elegans metabolic network would yield more significant correlations in
this type of analysis. These results suggest however, that highly connected,
or critical metabolites may be less likely to change with mutation than
less–critical metabolites. While correlation was seen between betweenness
centrality and propensity to change, no significant correlation was observed
between degree centrality and propensity of a metabolite to change. This
suggests that the number of links incident on a given metabolite may not be
a good indicator of how likely that metabolite is to change with mutation,
and that the overall load placed on a metabolite in a network appears to be
a more important factor.
Changes in only one metabolite, N-acetyl-L-histidine, were found to sig-
nificantly correlate with fitness, here based on fecundity, and defined as the
total number of eggs produced in the lifetime of a worm. It is not clear
what role this metabolite has in C. elegans. N-acetyl-L-histidine is known to
be present in the vertebrate nervous system, but its function is unknown
(Baslow, 1997).
Estes et al. (2004) found that DNA sequencing of C. elegans mutation
accumulation lines was able to reveal many evolutionary relevant mutations
that had no measurable effect on laboratory fitness. The fact that no
correlation was found between fitness and all but one of the metabolites
identified demonstrates that metabolic profiling is able to provide new
insights into the ‘silent’ effects of mutation accumulation.
Some of the MA lines received from the Baer lab did not survive the freezing
process required for storage prior to this experiment. It is possible that
these lines may have been some of the least fit MA lines. In addition to this,
some lines did not produce enough progeny to provide sufficient biomass
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for metabolomic analysis. The synchronisation of lines by hypochlorite
treatment may also have resulted in the loss of worms unable to survive the
process. However, this method provides the large number of synchronised
worms required and also ensures that plates are free of contamination, and
therefore was favoured over other synchronisation methods, such as allowing
individuals to lay eggs over a given period and then removing the first–
generation adults. These factors have contributed to the fact that this
analysis was unable to include some of the most unfit lines. Metabolic
profiling of these very unfit lines could have provided further insight into
the effect of mutation accumulation on the C. elegans metabolome, and may
have resulted in additional groupings being identified.
Additionally, on receiving the lines from the Baer lab, some bacterial
and fungal contamination could be seen on many of the plates. In order
to ensure only clean worms were frozen for storage, some worms from
uncontaminated areas of each plate were transferred to clean plates and
allowed to reproduce to give populations that were free of contamination.
Similarly, for sufficient biomass, worms were transferred by ‘chunking’ onto
new plates before synchronisation. It is possible that by selecting more than
one worm at these transfers, some lines were able to recover to some degree
as a result of natural selection. C. elegans MA lines are known to recover
quickly on the reintroduction of natural selection (Estes & Lynch, 2003;
Estes et al., 2011). However, at the time of sampling, all lines appeared to
have slightly smaller body sizes, reduced speed of movement and reduced
fecundity compared with the ancestral line, although no fitness assays were
carried out at this point. Ideally, fitness data should be obtained at this point
in order to help the interpretation of metabolomic data. While very little
correlation was identified between metabolomic data and the fitness data
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provided by the Baer lab, it may be the case that other measures of fitness,
such as body size, would better correlate with metabolomic data.
Conclusion
The accumulation of mutations over 250 generations results in significant
changes to the C. elegans metabolome. Using the fitness data available
for these MA lines, it is not possible to find links between these metabolic
changes and the fecundity phenotype. However, not all MA lines change in
the same way in terms of metabolism – it appears that the metabolism of
some lines is less affected by mutation accumulation than that of other lines.
These lines can be separated into two groups: one group containing lines
that have changed relatively little over 250 generations, and a second group
containing lines with metabolomes that have been more greatly affected
by the accumulation of mutations. In addition to this, the levels of some
metabolites appear to be more susceptible to change than others, with
the levels of some, presumably critical, metabolites remaining stable with
mutation accumulation. Initial analysis suggests that the propensity of a
metabolite to change, however, may not be linked with its centrality or
connectedness in a metabolic network. While changes in metabolic profile
were not found to correlate with the majority of the fitness data available
for these MA lines, this analysis has shown that metabolomics provides new
phenotypes and therefore novel information about variation that occurs as a
result of spontaneous mutation.
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Metabolomics for the study of ageing
While there is a clear link between changes in metabolism and changes in
longevity (discussed in section 1.3), there has been relatively little ageing–
related research investigating metabolism by measuring metabolites directly.
Research has generally concentrated on genes that control metabolism,
but this does not take into account regulation at post–transcriptional or
post–translational levels. Metabolomics – measuring low molecular weight
metabolites directly – has an advantage over other ‘omics’ techniques, in
that it directly samples the metabolic changes in an organism, and allows
for variation at the gene, transcript and protein levels, as well as post–
translational modification (ter Kuile & Westerhoff, 2001). In addition
to this, metabolites, as clearly defined chemical compounds, are directly
comparable between species, while genes and gene transcripts are often
species–specific.
Metabolic profiling not only allows the direct analysis of the metabolic
changes that occur with age, or may contribute to a long life, but also
provides new, intermediate phenotypes that may help distinguish between
individuals with a superficially similar ‘end–point’ phenotype – longevity.
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This is clearly demonstrated in Chapter 3, where three strains with lifespans
that are not seen to differ significantly from one another have distinct
metabolic profiles. Even daf-16 mutants, with wild type longevity, are
separable from wild type worms based on metabolic profile. While it has
been shown that low levels of DAF-16 may be found in the nuclei of wild type
worms (Cypser & Johnson, 2003; Weinkove et al., 2006), this experiment
shows just how sensitive metabolism may be to changes in an important
regulator of lifespan, even if no change in longevity is seen. In addition to
this, identifying those changes in metabolism that are dependent on the
function of this key regulator of ageing should help to focus future research,
by aiding the generation of testable hypotheses. By examining the metabolic
profile of mutants that are long–lived via a variety of different mechanisms –
IIS mutants, dietary restriction mutants, fertility mutants and so on, it may
be possible to identify a common metabolic signature of long life, or cluster
long–lived mutants into distinct groups.
A metabolic signature of long life
Branched–Chain Amino Acids
One metabolic signature that is seen to be associated with long life across all
experiments here, is an increase in the relative abundance of the Branched–
Chain Amino Acids (BCAAs) – isoleucine, leucine and valine. These are
seen to decrease with age in both wild type worms and in at least one daf-2
mutant (Chapter 5), and are found at increased concentration at a given
age in two of the daf-2 mutants tested here (Chapters 3 and 5) as well as in
other long–lived mutants (Fuchs et al., 2010). In addition to this, it has been
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shown that these changes are DAF-16 dependent (Chapter 3), suggesting
that these metabolites have a causal role in ensuring a long life. This finding
has since been replicated in C. elegans (Martin et al., 2011). The fact that
BCAAs are found at increased levels in protein translation mutant ife-2
(Fuchs et al., 2010), which has increased longevity that does not require
DAF-16, but appears to work either downstream or in parallel to DAF-2 to
regulate longevity, is an indication that these amino acids are important for
long–life, regardless of how long–life is conferred.
BCAAs have found to be important in the longevity of both yeast and
mice (Alvers et al., 2009; D’antona et al., 2010), where supplementation with
BCAAs has been found to increase lifespan. In a mouse model, an increase
in lifespan with BCAA supplementation is associated with increased mito-
chondrial biogenesis, with no lifespan extension seen in mice with mutations
impairing mitochondrial biogenesis. The treatment is also associated with
the up–regulation of ROS defence system genes, both processes contributing
to an overall decrease in oxidative damage. BCAA supplementation in
C. elegans also increases lifespan, although this has not yet been replicated
(Valbuena, pers. comm., 2011).
C. elegans is not able to synthesise BCAAs and so changes in pool sizes
depend on changes in the catabolism of BCAAs or in protein turnover. The
down–regulation of genes involved in the catabolism of BCAAs may be
responsible for the changes in BCAA pool sizes in long–lived daf-2 worms
(Fuchs et al., 2010), and it has been found that the transcripts of genes
associated with BCAA metabolism vary in other long–lived C. elegans
mutants (Martin et al., 2011).
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BCAA supplementation in mice increases the activity of mammalian
target–of–rapamaycin (TOR) complex 1 (mTORC1), a key regulator of cell
growth and protein synthesis in response to dietary amino acids (Valerio
et al., 2011). TOR protein kinases are involved in signalling in response
to environmental nutrient availability, and the C. elegans TOR homologue
regulates dauer diapause (Kim et al., 2002; Hara et al., 2002). It appears
that in mice, mTOR signalling activated by BCAA supplementation may
enhance biogenesis of mitochondria by increasing the generation of NO,
with endothelial nitric oxide synthase (eNOS) gene silencing decreasing the
activation of mTOR by BCAA supplementation (D’antona et al., 2010).
eNOS–derived nitric oxide directly increases mitochondrial biogenesis (Nisoli
et al., 2004) and eNOS Null mutant mice have age–related diseases at a
young age, a reduced lifespan, reduced mitochondrial biogenesis and reduced
SIRT1 expression (Li et al., 2004). While changes in mTOR signalling have
been suggested as a possible mechanism involved in increased longevity by
dietary restriction, whether signalling is up– or down– regulated may depend
on age and type of dietary restriction applied (reviewed in Valerio et al.,
2011).
One hypothesis has been put forward to attempt to explain why dietary
supplementation with BCAAs promotes mitochondrial biogenesis. Valerio
et al. (2011) suggest that an increase in dietary BCAAs induces mitochondrial
biogenesis in order to promote amino acid catabolism itself. Amino acids
are key precursors of components of the citric acid cycle, and the catabolism
of amino acids lead to ammonia production. Ammonia is metabolised via
the urea cycle, which occurs, in part, in the mitochondrial matrix.
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Leucine in particular appears to be important in mTOR signalling, with
leucine deprivation in mammalian cell culture media inhibiting mTOR
signalling (Haar et al., 2007). Leucine also acutely stimulates the secretion
of insulin from pancreatic B cells (Yang et al., 2010), and rats fed leucine
show an increase in serum insulin (Garlick, 2005). BCAAs are found to be
increased in worms with mutations a gene encoding insulin–like peptide,
daf-28 (Fuchs et al., 2010) as well as in daf-2 worms, with mutations affecting
the insulin–like receptor. This link between leucine and insulin signalling
could point to a mechanism behind the increased pools of this BCAA seen
in insulin signalling mutants.
Trehalose
Trehalose levels were found not to be DAF-16 dependent with either NMR or
GC–MS analysis (Chapter 3). This is consistent with findings that lifespan
extension with trehalose in wild type worms does not require DAF-16, and
that trehalose treatment does not promote the translocation of DAF-16
to nuclei, or increase the expression of sod-3, a known target of DAF-16
(Honda et al., 2010). However, daf-2 worms show no increased longevity
with trehalose treatment, and RNAi inactivation of trehalose biosynthesis
genes in daf-2 worms results in a large decrease in lifespan, compared with
a small decrease in lifespan in wild type worms (Honda et al., 2010). This
suggests that daf-2 mutation and treatment with trehalose extend lifespan
via a common mechanism, with daf-2 regulating levels of trehalose via a
transcription factor that acts parallel to DAF-16, and that trehalose functions
as a suppressor of ageing under control of IIS (Honda et al., 2010).
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In addition to being elevated in the daf-2 mutants studied here, trehalose
levels have been found to be elevated in age-1 mutants, dauers, and the
long–lived translation–defective mutant (where longevity is not DAF-16
dependent) described above (Fuchs et al., 2010), and genes involved in its
synthesis are known to be upregulated in IIS mutants (Lamitina & Strange,
2005; McElwee et al., 2006), implying that this metabolite may still have
a role in longevity. Trehalose levels change differently in wild type and
daf-2 mutants as they age (Chapter 5). In wild type worms, trehalose
levels decrease with age, while in long–lived daf-2(m41), levels increase with
age.
Trehalose treatment has been shown to enhance thermotolerance, and
RNAi inactivation of trehalose biosynthesis genes increase the sensitivity of
C. elegans to heat stress (Honda et al., 2010). Many links between enhanced
heat–stress tolerance and increased lifespan have been found (Lithgow et al.,
1995; Gems et al., 1998; Hertweck et al., 2004), with trehalose–mediated
thermotolerance mechanisms thought to be a result of the stabilising of
protein structures; trehalose prevents both protein denaturation as a result
of heat, and the aggregation of misfolded proteins (Singer & Lindquist, 1998;
Jain & Roy, 2008).
Honda et al. (2010) found that trehalose appears to lengthen C. elegans
healthspan as well as lifespan, with both mean and maximum lifespan in-
creased with trehalose treatment, along with a lengthened reproductive
span and slowing of age–associated phenotypes such as the decline in pha-
ryngeal pumping rate. Based on age–specific mortality rates, the authors
conclude that trehalose lowers age–dependent vulnerability to both internal
and external stresses, rather than reducing the intrinsic rate of ageing. The
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authors suggest that trehalose protects against the increased stress that
occurs with age, but is unable to repair damage to proteins that has already
occurred during the ageing process. This can be directly linked with the
pattern of change in trehalose levels with age observed here (Chapter 3,
Figure 5.16).
Metabolomics for Mutation Accumulation
studies
The type of analysis carried out using mutation accumulation (MA) lines
here differs from that used in the majority of MA experiments. Most
MA experiments are concerned with determining the rate of spontaneous
mutation, however the purpose of using metabolic profiling to study MA
lines here was to study the phenotypic impact of mutations, rather than
the rate of mutation. While determining the rate of spontaneous mutation
is important in understanding many biological processes, including genetic
disease and the evolution of sex, in addition to the evolution of ageing,
there is debate over the use of mutation accumulation experiments over
many generations as a reliable way to measure per–generation mutation
rate (reviewed by Kondrashov & Kondrashov, 2010). Measuring mutation
rate is difficult for a number of reasons. Firstly, the per–nucleotide rate
of mutation is very low, particularly in eukaryotes. In addition to this,
the random nature of mutation makes it difficult to know when and where
mutation might occur. The rates of different mutation–types (such as point
mutations and large–scale mutations) need to be measured separately, and
ideally mutation rates should take into account varying genetic backgrounds,
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in addition to various mutation–types. Lastly, the mutation rate is heavily
influenced by the environment, and the rate of mutation itself is subject to
selection and evolution (Kondrashov & Kondrashov, 2010).
Mutation rate may be measured in various ways (reviewed by Kondrashov
& Kondrashov, 2010), including the use of fitness data from MA experiments
to estimate per–generation mutation rates. However mildly deleterious
mutations may not be detected, and it is known that many evolutionary
relevant mutations have no measurable effect on laboratory fitness (Estes
et al., 2004). This first metabolomic analysis of mutation accumulation
has demonstrated that metabolic profiling is able to reveal new phenotypes
that are affected by mutation accumulation in C. elegans, and that these
phenotypes are not necessarily associated with fitness (Chapter 6). However,
estimating per–generation mutation rates with these data would require
more than the single ancestral line profiled here as control lines (Baer et al.,
2006).
It is known that the most highly connected proteins in a cell are the most
important for survival, with the deletion of these proteins associated with a
lethal phenotype (Jeong et al., 2001). However, the propensity of a given
metabolite to change with the accumulation of mutations does not correlate
with the available values (based on a mouse model) for metabolite centrality
or connectedness. Analysis by Mahadevan & Palsson (2008) suggests that in
genome–scale metabolic networks, even the least connected metabolites are
as critical to the overall network as the most connected nodes, and this may
explain these findings. Despite this, it may be the case that results based
on a C. elegans–specific metabolic network may be different. The fact that
changes in metabolite levels did not correlate with fitness (for all but one
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metabolite) adds to the difficulty in interpreting these results. Additionally,
the propensity to change may correlate with other network properties of a
metabolite. Further work in this area is needed, but metabolomic analysis
of mutation accumulation may still provide information about the network
properties of metabolites.
How can we interpret metabolomic data?
Metabolic profiling generates large amounts of data. One of the issues
raised with this approach is the question of how to interpret this data – it
is often difficult to link changes in metabolite levels with the reasons and
mechanisms behind these changes. The fact that there are fewer metabolites
than there are genes or gene products means that it is not possible to
find direct relationships between metabolites and genes (Raamsdonk et al.,
2001). Mutations may have a small, or silent effect on phenotypes such
as growth rate because the concentration of intracellular metabolites are
altered to compensate for the mutation. By quantifying the relative changes
of metabolite concentrations that occur as a result of ‘silent’ mutations, it
should be possible to identify the site of action of the product of a gene, and
to identify new, silent, regulatory genes (Raamsdonk et al., 2001).
The number of metabolites identified and quantified here, with this un-
targeted analysis, is generally not sufficient for linking changing pool sizes
with pathways. Identifying more metabolites may help this type of pathway–
based analysis. One way to go about interpreting metabolic data in terms
of networks and pathways is the use of mathematical modelling. Broadly,
there are two approaches to modelling: genome–scale modelling, and kinetic
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modelling. In addition to this, results may be interpreted using a statistical
approach.
Genome–scale modelling
Genome–scale metabolic modelling involves reconstructing a model of the
metabolic network of a given organism based on an annotated genome
sequence (Fell et al., 2010). The ideal would be a database of all reactions
and metabolites that could possibly occur in an organism, complete with
their linking all enzymes and proteins to their associated genes.
The definition of the stoichiometries of many reactions, and the grouping
of shared metabolites have helped to define traditional pathways (Papin
et al., 2003). Constraint–based genome–scale modelling determines the opti-
mal path through a stoichiometric network within certain physicochemical
constraints (Smallbone et al., 2007). Genome–scale modelling makes use
of genome annotation to describe the components of a metabolic network,
along with parameters such as cellular growth and flux (Papin et al., 2003).
Metabolic flux is the way in which metabolites passage through a reaction
with time (Zamboni & Sauer, 2009), and fluxes vary less than do metabo-
lite pools with mutation (Raamsdonk et al., 2001). Metabolic flux can be
determined directly, using time course data, where pathway intermediates
are enriched with stable, dynamic isotopes. They may also be inferred using
macroscopic uptake and production rates, with steady state isotope–labelling
of metabolites. Both metabolic flux analysis (Bonarius et al., 1997) and flux
balance analysis (Varma & Palsson, 1994) use steady state conditions, where,
in a given network, all metabolite concentrations are constant, though there
may be flux through the reactions (Fell et al., 2010).
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Schilling et al. (1999) used this approach in an attempt to predict genotype–
phenotype relationships in E. coli, creating a stoichiometric model to describe
all known reactions in E. coli cells, and predicting phenotypes for various
deletion mutants. Predictions made using this model were accurate in around
90% of deletion mutants examined.
This type of modelling does not make use of metabolite concentrations or
enzyme connections in its parameters, so requires minimal biological data,
however this means that it is not able to predict changes in metabolite or
enzyme concentrations (Smallbone et al., 2007).
Kinetic modelling
Kinetic modelling aims to simulate the dynamics of a system (Smallbone
et al., 2007). It combines mechanistic rate equations with kinetic parameters
such as metabolite concentrations, enzyme concentrations and Vmax (the
maximum rate achieved by a system at saturating substrate concentrations)
to fully characterise the mechanics of each reaction in a network. This type
of modelling attempts to predict how changes in metabolite concentrations
may affect local reaction rates.
This approach has been used to model many processes in microbes, includ-
ing glycolysis (Rizzi et al., 1997), the pentose phosphate pathway (Vaseghi
et al., 1999) and central nitrogen metabolism (van Riel et al., 1998) in the
yeast S. cerevisiae. These models apply to very short time scales, however
(Rizzi et al., 1997), and therefore do not take into account enzyme syn-
thesis and degradation, which would be an important factor over larger
timescales.
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In contrast to genome–scale modelling, kinetic modelling requires a large
amount of data, with models requiring many parameters, and this is generally
both time–consuming and expensive. In addition to this, is it often difficult to
determine many parameters experimentally (Smallbone et al., 2007).
Statistical interpretation
One way to interpret data involves the use of enrichment or over–representation
analysis. Enrichment analysis is a computational method that determines
whether a defined set of metabolites differ significantly between two pheno-
types. This type of approach is common in the analysis of gene expression
data sets (Khatri & Draghici, 2005), but may also be used for metabolomic
analysis (Subramanian et al., 2005; Xia & Wishart, 2010; Chagoyen & Pazos,
2011). A set of metabolites that are found to be correlated with a phenotype
of interest is selected and compared with a priori–defined sets of metabo-
lites, i.e., metabolites that are grouped based on prior biological knowledge,
using databases of metabolite annotations specific to a particular organism
(Chagoyen & Pazos, 2011). This helps to identify sets of metabolites that
show greater overlap with metabolites associated with a particular pheno-
type than would be expected by chance, generating a list of significantly
over–represented or ‘enriched’ pathways or metabolite sets that may be used
to aid the biological interpretation of the data (Cavill et al., 2011).
Are these techniques applicable to C. elegans metabolomics
studies?
While the modelling methods described are clearly very useful for the bi-
ological interpretation of metabolomics data, the main obstacle in using
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these approaches in C. elegans metabolomics studies is that there are no
C. elegans metabolic models available, and no agreed metabolic networks.
This type of approach would require the generation of metabolic networks
specific to C. elegans, as well as the stoichiometry associated with each
reaction. Additionally, the problems associated with the modelling of whole
multicellular organisms would need to be addressed. Both genome–scale
modelling and kinetic modelling work best in single–cellular organisms such
as yeast or bacteria, and are more complex and less effective in multicellular
organisms such as C. elegans, where there are a variety of different cell types
containing enzymes specific to a given cell type.
Constraints–based modelling has been applied to ageing in Drosophila
(Feala et al., 2007; Coquin et al., 2008), with the investigation of the decline
in hypoxia tolerance with age. Here, metabolomics, the annotated Drosophila
genome, and existing Drosophila metabolic models were combined to generate
hypotheses for the biological mechanisms behind this changing phenotype.
The problems of modelling in organisms other than microbes were overcome
by using just one tissue–type – muscle.
In addition to this, these models are better suited to examining rapid
changes, rather than slow changes such as development, ageing, or the
accumulation of mutations, and most functional analysis focuses only on
changes produced by the mutation of a single enzyme. The genetic control
of ageing is linked with receptors, such as DAF-2, and transcription factors,
such as DAF-16. Mutations in the genes associated with these proteins
produce multiple changes, unlike a mutation in a single enzyme. While the
work required for modelling C. elegans metabolism is beyond the scope of
this thesis, further studies would benefit from this approach.
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Of the methods of interpreting metabolomic data described, enrichment
or overrepresentation analysis is most applicable to C. elegans metabolomics
studies. However, the relatively small number of metabolites identified here,
even with the use of a relatively sensitive platform such as GC–MS, means
that there is little power to obtain a substantial amount of additional insight
using these techniques. The identification and quantification of a larger
number of metabolites would give more power to this approach.
Additionally, it is not always possible to link changes identified in a
particular pathway with the mechanisms behind these changes, as metabolites
often contribute to multiple pathways. It is also difficult to define pathways,
and although pathway databases such as KEGG (Kyoto Encyclopedia of
Genes and Genomes (Kanehisa, 2006)) exist, pathway definitions are often
arbitrary.
The use of metabolomics for C. elegans ageing
research: advantages and limitations
The metabolic profiling of C. elegans here has allowed the prediction of results
of research published subsequently (D’antona et al., 2010; Honda et al., 2010).
Epistasis analysis and life cycle analysis both predicted the importance of
branched–chain amino acids in longevity. That these metabolites, when
fed to mice (D’antona et al., 2010), would increase lifespan, could have
been predicted using metabolomic analysis. Similarly, the importance of the
timing of trehalose treatment in extending C. elegans lifespan (Honda et al.,
2010) could have been predicted using relative changes in trehalose levels
that occur naturally in worms as they age. It is possible to see these changes
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without modelling or complex statistical analysis, and this demonstrates the
usefulness of metabolomic analysis in ageing research; it identifies longevity–
related metabolites, and helps to generate easily–testable hypotheses. A next
step would be to test the effects of other DAF-16 repressible metabolites such
as dopamine, putrescine, adenosine, citrate and phenylalanine (Chapter 3,
section 3.2.2) on C. elegans lifespan.
Here, the epistatic interaction between daf-2 and daf-16 helped to focus
on metabolites that appeared to have a causal role in longevity, based on
the known importance of DAF-16 in longevity. By studying other epistatic
interactions linked with longevity, for example, the eat-2 / pha-4 pathway
thought to be involved in lifespan extension by dietary restriction (Panowski
et al., 2007), it should be possible to identify common, or new metabolites
important for increased lifespan. This type of approach, along with the iden-
tification of a greater number of metabolites, may help establish additional
signatures of longevity.
As discussed, to find a true ‘signature of longevity’, many different life
span mutants, with longevity altered by a variety of mechanisms, would need
to be analysed. Any common metabolic features across mutants would help
provide a real insight into what, on a metabolic level, helps promote long life.
However, this would require the identification and quantification of many
more metabolites that have been detected here, so that metabolites important
in longevity are not overlooked – currently it is difficult to know how many
of the total metabolites in an organism are being detected (Weckwerth &
Morgenthal, 2005).
Metabolomics also yields interesting results with pattern recognition–type
analysis. For example, using a model wild type metabolic profile, daf-2
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worms are predicted to be younger than their chronological age in both
development and adulthood, and this is consistent with the fact that long–
lived daf-2 worms can be seen to age more slowly than wild type worms,
remaining fertile and more active for longer than wild type worms (Kenyon
et al., 1993; Morris et al., 1996; Kimura, 1997), with the increase in lifespan
relative to wild type worms in long–lived mutants including age-1, clk-1 and
daf-2 occurs post–reproduction (Friedman & Johnson, 1988; Chen et al.,
2007). Assessing the changes in metabolism with age and the differences
in these changes in long–lived individuals allows us to begin to answer the
question of whether long–lived mutants simply have a reduced rate of ageing,
or whether they follow completely different ageing trajectories, with different
metabolic changes. These type of analyses are useful, despite the fact that
the results may not be interpretable mechanistically.
Conclusion
In this thesis, I have demonstrated that metabolic profiling provides a new
and useful phenotyping tool for studying ageing in the nematode Caenorhab-
ditis elegans. Using two platforms, I have identified metabolites that are
linked to long life. I have carried out the first characterisation of the C. el-
egans metabolome throughout both development and ageing. Comparing
these metabolic changes in wild type worms with those seen in a long–lived
mutant aid the understanding of when and how mutant worms acquire their
long–lived phenotype. In addition to this, I have examined the effects on
metabolism of a commonly–used technique in C. elegans ageing research:
the inhibition of DNA synthesis to maintain synchronous populations. This
provided a way to control for the effects of this technique when used in my
190
work, but also demonstrated that its use may result in artefacts in data.
I have also carried out the first study of the effect of mutation accumula-
tion on the C. elegans metabolic profile. I have shown that metabolomics
provides a way to obtain new phenotypes in this type of experiment, and
novel information about the variation that occurs as a result of spontaneous
mutation.
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